RESULT_COUNT: 282,PAGE_SIZE: 10000,CURRENT_PAGE: 1,TOTAL_PAGES: 1,API_CALL_CREDITS: 1
TICKER,FIGI_TICKER,FIGI,TITLE,PUBLICATION_DATE,URL,SUMMARY
SUPN,SUPN:US,BBG000BP0HX7,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Supernus Pharmaceuticals, Inc.",2017-10-20 21:39:00 +0000,https://finance.yahoo.com/news/shareholder-alert-levi-korsinsky-llp-213900109.html?.tsrc=rss,"Levi & Korsinsky announces it has commenced an investigation of Supernus Pharmaceuticals, Inc. concerning possible violations of federal securities laws."
SUPN,SUPN:US,BBG000BP0HX7,"ETFs with exposure to Supernus Pharmaceuticals, Inc. : October 17, 2017",2017-10-17 14:01:25 +0000,http://finance.yahoo.com/r/271743ee-8b44-3c33-b23e-659cbc9a9390/etfs-with-exposure-to-supernus-pharmaceuticals-inc-october-17-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Supernus Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to SUPN-US. Comparing the performance and risk of Supernus Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
SUPN,SUPN:US,BBG000BP0HX7,"ETFs with exposure to Supernus Pharmaceuticals, Inc. : October 6, 2017",2017-10-06 15:06:41 +0000,http://finance.yahoo.com/r/3e4d0bed-eb8e-3e33-b765-e27292dc56ab/etfs-with-exposure-to-supernus-pharmaceuticals-inc-october-6-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Supernus Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to SUPN-US. Comparing the performance and risk of Supernus Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
SUPN,SUPN:US,BBG000BP0HX7,See what the IHS Markit Score report has to say about Supernus Pharmaceuticals Inc.,2017-10-04 12:06:37 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120637263.html?.tsrc=rss,Supernus Pharmaceuticals Inc NASDAQ NMS:SUPN
SUPN,SUPN:US,BBG000BP0HX7,"ETFs with exposure to Supernus Pharmaceuticals, Inc. : September 26, 2017",2017-09-26 15:06:04 +0000,http://finance.yahoo.com/r/27327efc-78a1-38a1-a11d-f4f62eb279be/etfs-with-exposure-to-supernus-pharmaceuticals-inc-september-26-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Supernus Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to SUPN-US. Comparing the performance and risk of Supernus Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
SUPN,SUPN:US,BBG000BP0HX7,"Supernus Pharmaceuticals, Inc. :SUPN-US: Earnings Analysis: Q2, 2017 By the Numbers : September 25, 2017",2017-09-25 12:50:52 +0000,http://finance.yahoo.com/r/0ed27cc4-16c7-328f-b6c1-e591f7a4f185/supernus-pharmaceuticals-inc-supn-us-earnings-analysis-q2-2017-by-the-numbers-september-25-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Supernus Pharmaceuticals, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Supernus Pharmaceuticals, Inc. – United Therapeutics Corporation, Zogenix, Inc., Alcobra Ltd., Bristol-Myers Squibb Company, Eli Lilly and Company and Shire PLC Sponsored ADR (UTHR-US, ZGNX-US, ADHD-US, BMY-US, LLY-US ... Read more
<b>(Read more...)</b>"
SUPN,SUPN:US,BBG000BP0HX7,"Pharma Stock Roundup: Pfizer Files Suit against J&J, Supernus Hit by Study Update",2017-09-22 12:42:12 +0000,https://finance.yahoo.com/news/pharma-stock-roundup-pfizer-files-124212253.html?.tsrc=rss,Industry heavyweights like Pfizer (PFE) and Johnson & Johnson were in the news this week related to a lawsuit while Glaxo got FDA approval for a key drug.
SUPN,SUPN:US,BBG000BP0HX7,Supernus Pharmaceuticals Hits 80-Plus Relative Strength Rating Benchmark,2017-09-22 07:00:00 +0000,http://finance.yahoo.com/r/7c8eb4a9-1647-3408-9034-0a83676dfe50/supernus-pharmaceuticals-hits-80-plus-relative-strength-rating-benchmark?src=A00220&yptr=yahoo&.tsrc=rss,Supernus Pharmaceuticals sees its Relative Strength Rating hit the 80-plus level.
SUPN,SUPN:US,BBG000BP0HX7,"IPXL Mulls Merger, QURE Attracts Attention, No Let Up In ICPT Ocaliva Concerns",2017-09-21 20:30:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/n1Br6rKkbIA/ipxl-mulls-merger-qure-attracts-attention-no-let-up-in-icpt-ocaliva-concerns-20170921-01187,"IPXL Mulls Merger, QURE Attracts Attention, No Let Up In ICPT Ocaliva Concerns"
SUPN,SUPN:US,BBG000BP0HX7,"Supernus Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : SUPN-US : September 20, 2017",2017-09-20 13:59:40 +0000,http://finance.yahoo.com/r/11fcef10-7985-34eb-aa31-bc1e98a98c92/supernus-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bearish-manner-supn-us-september-20-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Supernus Pharmaceuticals, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish ... Read more
<b>(Read more...)</b>"
SUPN,SUPN:US,BBG000BP0HX7,Today's Research Reports on Stocks to Watch: Capricor Therapeutics and Supernus Pharmaceuticals,2017-09-20 12:20:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-122000458.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / September 20, 2017 / Traders can hardly wait for Capricor Therapeutics to release six-month follow-up data from its Hope-Duchenne clinical trial of CAP-1002. Shares skyrocketed ..."
SUPN,SUPN:US,BBG000BP0HX7,Why Supernus Pharmaceuticals' Shares Plummeted 23.4% Today,2017-09-19 22:37:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cSA_ZkXDvjY/why-supernus-pharmaceuticals-shares-plummeted-234-today-cm848065,What happened After reporting disappointing interim news from its phase 3 study of SPN 810 as a treatment for aggressive impulses in ADHD patients shares in Supernus Pharmaceuticals NASDAQ SUPN tumbled 23 4 today So what Supernus Pharmaceuticals markets
SUPN,SUPN:US,BBG000BP0HX7,"CAPR Is Hot, VBLT In Rally Mode, MYOK's Data Heartening, MediWound Bleeds",2017-09-19 21:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/If_59Lyxdws/capr-is-hot-vblt-in-rally-mode-myoks-data-heartening-mediwound-bleeds-20170919-01399,"CAPR Is Hot, VBLT In Rally Mode, MYOK's Data Heartening, MediWound Bleeds"
SUPN,SUPN:US,BBG000BP0HX7,Supernus Drops SPN-810's Lower Dose Test in Phase III Trials,2017-09-19 21:37:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qB7wi7SLbMU/supernus-drops-spn-810s-lower-dose-test-in-phase-iii-trials-cm848039,Supernus Pharmaceuticals Inc s SUPN shares have dropped almost 10 after the company announced decision to stop evaluating the lower dose option 18 mg of its pipeline candidate SPN 810 in two phase III clinical trials However the company will carry on with its 36 mg dose of SPN 810
SUPN,SUPN:US,BBG000BP0HX7,"Noteworthy Tuesday Option Activity: SUPN, WTW, AMT",2017-09-19 20:36:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/X_FN3Gw6VUc/noteworthy-tuesday-option-activity-supn-wtw-amt-cm847987,Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Supernus Pharmaceuticals Inc Symbol SUPN where a total volume of 2 997 contracts has been traded thus far today a contract volume which is representative of
SUPN,SUPN:US,BBG000BP0HX7,Why Supernus Pharmaceuticals&apos; Shares Plummeted 23.4% Today,2017-09-19 20:29:00 +0000,http://finance.yahoo.com/r/2e13f08c-ed57-3d0b-95ae-ca29b75644ca/why-supernus-pharmaceuticals-share-are-crashing-22.aspx?yptr=yahoo&.tsrc=rss,A change to phase 3 trials evaluating its lead product candidate SPN-810 fueled investors&apos; pessimism.
SUPN,SUPN:US,BBG000BP0HX7,Supernus Drops SPN-810&apos;s Lower Dose Test in Phase III Trials,2017-09-19 19:12:07 +0000,https://finance.yahoo.com/news/supernus-drops-spn-810-apos-191207223.html?.tsrc=rss,"Supernus (SUPN) decides to stop evaluating the lower dose option of SPN-810 for treatment of impulsive aggression. However, the company will carry on with the study of higher dose arm or placebo."
SUPN,SUPN:US,BBG000BP0HX7,MediWound Shares Lower After Pricing Stock Offering - Biotech Movers,2017-09-19 13:28:00 +0000,http://finance.yahoo.com/r/b4822b98-f026-3ba4-8740-e60cafb33d54/mediwound-shares-down-after-pricing-stock-offering.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,MediWound priced an underwritten public offering of 4.4 million shares at $5 apiece.
SUPN,SUPN:US,BBG000BP0HX7,Supernus shares decline on drug study change,2017-09-18 21:50:50 +0000,http://finance.yahoo.com/r/5fd14ad6-dfd9-3846-852c-b64d63f6321e/Story.aspx?guid=0DAE029B-4B1D-4CA5-9494-327AD88DE456&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Supernus Pharmaceuticals Inc. shares declined late Monday after the drug maker said it has altered a study of a child aggression treatment under advice from a third-party statistician. Supernus shares ...
SUPN,SUPN:US,BBG000BP0HX7,Supernus Provides Update on SPN-810 Phase III Clinical Trials,2017-09-18 20:04:14 +0000,https://finance.yahoo.com/news/supernus-provides-spn-810-phase-200414925.html?.tsrc=rss,"ROCKVILLE, Md., Sept. 18, 2017-- Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, ..."
SUPN,SUPN:US,BBG000BP0HX7,See what the IHS Markit Score report has to say about Supernus Pharmaceuticals Inc.,2017-09-11 12:04:01 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120401587.html?.tsrc=rss,Supernus Pharmaceuticals Inc NASDAQ NMS:SUPN
SUPN,SUPN:US,BBG000BP0HX7,These 4 Biotechs Just Moved Into Buy Zones; Is This Giant Next?,2017-09-01 11:45:46 +0000,http://finance.yahoo.com/r/3177b128-03e5-3556-8021-991ed8c0fd9f/these-4-biotechs-just-moved-into-buy-zones-sp-500-futures?src=A00220&yptr=yahoo&.tsrc=rss,Several biotech stocks broke out Thursday as the Nasdaq composite and other major averages approached all-time highs. Celgene could be next.
SUPN,SUPN:US,BBG000BP0HX7,See what the IHS Markit Score report has to say about Supernus Pharmaceuticals Inc.,2017-08-29 12:05:23 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120523145.html?.tsrc=rss,"Short interest is moderately high for SUPN with between 10 and 15% of shares outstanding currently on loan.  This represents an increase in short interest as investors who seek to profit from falling equity prices added to their short positions on August 25.  Over the last month, growth of ETFs holding SUPN is favorable, with net inflows of $4.44 billion."
SUPN,SUPN:US,BBG000BP0HX7,See what the IHS Markit Score report has to say about Supernus Pharmaceuticals Inc.,2017-08-24 12:04:46 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120501984.html?.tsrc=rss,"Short interest is moderate for SUPN with between 5 and 10% of shares outstanding currently on loan.  The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Over the last month, ETFs holding SUPN are favorable, with net inflows of $3.31 billion."
SUPN,SUPN:US,BBG000BP0HX7,"Ashford Capital Management Inc Buys Motorcar Parts of America Inc, State National Inc, The ...",2017-08-22 13:37:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Oor8j0y4U_Y/ashford-capital-management-inc-buys-motorcar-parts-of-america-inc-state-national-inc-the-cm835227,Ashford Capital Management Inc New Purchases MPAA SNC AAXN MARK BABA GE Added Positions TTD CVCO STMP NEWR FNV CHGG VSAT EFA XPER EBIX Reduced Positions BABY CPRT AGG MDSO SHOP VTI AGX INFO AMZN MDCO Sold Out UHAL LKQ
SUPN,SUPN:US,BBG000BP0HX7,"ALXN's Strengthening Patents, FOLD's Fabry Drug Approved In OZ, VBIV Surges",2017-08-16 02:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UPeOCxT4xeY/alxns-strengthening-patents-folds-fabry-drug-approved-in-oz-vbiv-surges-20170816-00044,"ALXN's Strengthening Patents, FOLD's Fabry Drug Approved In OZ, VBIV Surges"
SUPN,SUPN:US,BBG000BP0HX7,"Supernus Pharmaceuticals, Inc. – Value Analysis (NASDAQ:SUPN) : August 15, 2017",2017-08-15 22:55:25 +0000,http://finance.yahoo.com/r/79abac8f-08e5-3798-95fb-a0b6c0aa90c1/supernus-pharmaceuticals-inc-value-analysis-nasdaqsupn-august-15-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Supernus Pharmaceuticals, Inc. a score of 88. Our analysis is based on comparing Supernus Pharmaceuticals, Inc. with the following peers – United Therapeutics Corporation, Zogenix, Inc., Alcobra Ltd., Bristol-Myers Squibb Company, Eli Lilly and Company, Shire PLC Sponsored ADR, Johnson & Johnson and Abbott Laboratories (UTHR-US, ZGNX-US, ... Read more
<b>(Read more...)</b>"
SUPN,SUPN:US,BBG000BP0HX7,Supernus Defeats Second Generic Challenger to Oxtellar XR®,2017-08-15 20:45:00 +0000,https://finance.yahoo.com/news/supernus-defeats-second-generic-challenger-204500945.html?.tsrc=rss,"ROCKVILLE, Md., Aug. 15, 2017-- Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, ..."
SUPN,SUPN:US,BBG000BP0HX7,"Supernus Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : SUPN-US : August 15, 2017",2017-08-15 13:09:51 +0000,http://finance.yahoo.com/r/a683d716-f371-3a1b-9d4b-0c459865959a/supernus-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bullish-manner-supn-us-august-15-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Supernus Pharmaceuticals, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bullish ... Read more
<b>(Read more...)</b>"
SUPN,SUPN:US,BBG000BP0HX7,See what the IHS Markit Score report has to say about Supernus Pharmaceuticals Inc.,2017-08-14 12:05:03 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120503131.html?.tsrc=rss,Supernus Pharmaceuticals Inc NASDAQ NMS:SUPN
SUPN,SUPN:US,BBG000BP0HX7,Edited Transcript of SUPN earnings conference call or presentation 3-Aug-17 1:00pm GMT,2017-08-14 00:06:13 +0000,https://finance.yahoo.com/news/edited-transcript-supn-earnings-conference-204648421.html?.tsrc=rss,Q2 2017 Supernus Pharmaceuticals Inc Earnings Call
SUPN,SUPN:US,BBG000BP0HX7,See what the IHS Markit Score report has to say about Supernus Pharmaceuticals Inc.,2017-08-11 12:04:30 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120430293.html?.tsrc=rss,"Short interest is moderate for SUPN with between 5 and 10% of shares outstanding currently on loan.  The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Investors are committing new capital to ETFs that hold SUPN at an increasing rate, with the one-month net inflow having reached $451 million."
SUPN,SUPN:US,BBG000BP0HX7,See what the IHS Markit Score report has to say about Supernus Pharmaceuticals Inc.,2017-08-10 12:04:02 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120402909.html?.tsrc=rss,"Short interest is moderate for SUPN with between 5 and 10% of shares outstanding currently on loan.  The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Investors are committing new capital to ETFs that hold SUPN at an increasing rate, with the one-month net inflow having reached $209 million."
SUPN,SUPN:US,BBG000BP0HX7,See what the IHS Markit Score report has to say about Supernus Pharmaceuticals Inc.,2017-08-09 12:04:33 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120433241.html?.tsrc=rss,"Short interest is moderate for SUPN with between 5 and 10% of shares outstanding currently on loan.  The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Investors are committing new capital to ETFs that hold SUPN at an increasing rate, with the one-month net inflow having reached $949 million."
SUPN,SUPN:US,BBG000BP0HX7,"Investor Network: Supernus Pharmaceuticals, Inc. to Host Earnings Call",2017-08-03 11:10:00 +0000,https://finance.yahoo.com/news/investor-network-supernus-pharmaceuticals-inc-111000526.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / August 3, 2017 / Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN ) will be discussing their earnings results in their Q2 Earnings Call to be held on Thursday, August 3, 2017 at ..."
SUPN,SUPN:US,BBG000BP0HX7,Supernus tops Street 2Q forecasts,2017-08-03 04:23:12 +0000,https://finance.yahoo.com/news/supernus-tops-street-2q-forecasts-022427249.html?.tsrc=rss,"The Rockville, Maryland-based company said it had net income of 32 cents per share. The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research ..."
SUPN,SUPN:US,BBG000BP0HX7,Supernus Announces Record Second Quarter 2017 Financial Results,2017-08-02 20:15:00 +0000,https://finance.yahoo.com/news/supernus-announces-record-second-quarter-201500612.html?.tsrc=rss,"Second quarter net product sales were $73.3 million, a 46% increase over 2016. Strong acceleration in Trokendi XR prescription growth following April launch in migraine prophylaxis in adults and adolescents. ..."
SUPN,SUPN:US,BBG000BP0HX7,"ETFs with exposure to Supernus Pharmaceuticals, Inc. : August 1, 2017",2017-08-01 21:20:50 +0000,http://finance.yahoo.com/r/480a5cff-66f9-3d2b-ba85-30071527609a/etfs-with-exposure-to-supernus-pharmaceuticals-inc-august-1-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Supernus Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to SUPN-US. Comparing the performance and risk of Supernus Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
SUPN,SUPN:US,BBG000BP0HX7,"Supernus Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : SUPN-US : August 1, 2017",2017-08-01 13:22:31 +0000,http://finance.yahoo.com/r/1c57d51d-a35c-37dd-ae1d-ed6ee7310763/supernus-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bearish-manner-supn-us-august-1-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Supernus Pharmaceuticals, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish ... Read more
<b>(Read more...)</b>"
SUPN,SUPN:US,BBG000BP0HX7,Supernus to Host Second Quarter 2017 Earnings Conference Call,2017-07-19 20:05:00 +0000,https://finance.yahoo.com/news/supernus-host-second-quarter-2017-200500809.html?.tsrc=rss,"ROCKVILLE, Md., July 19, 2017-- Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, ..."
SUPN,SUPN:US,BBG000BP0HX7,Cramer's lightning round: I'm all in on this financial wi...,2017-07-18 22:58:00 +0000,https://finance.yahoo.com/video/cramers-lightning-round-im-financial-225800039.html?.tsrc=rss,"Jim Cramer flies through his take on callers' favorite stocks at lightning speed, including one asset manager."
SUPN,SUPN:US,BBG000BP0HX7,Cramer's lightning round: I'm all in on this financial with great leadership,2017-07-18 22:49:05 +0000,http://finance.yahoo.com/r/92097027-5c66-358a-aba4-767239185106/104593363?__source=yahoo%7Cfinance%7Cheadline%7Cheadline%7Cstory&par=yahoo&doc=104593363&yptr=yahoo&.tsrc=rss,"Jim Cramer flies through his take on callers' favorite stocks at lightning speed, including one asset manager."
SUPN,SUPN:US,BBG000BP0HX7,Cramer&apos;s lightning round: I&apos;m all in on this financial with great leadership,2017-07-18 22:49:05 +0000,https://finance.yahoo.com/news/cramer-apos-lightning-round-apos-224905692.html?.tsrc=rss,"Jim Cramer flies through his take on callers&apos; favorite stocks at lightning speed, including one asset manager."
SUPN,SUPN:US,BBG000BP0HX7,"Gainers & Losers Of July 17: ACRX, QDEL, AKCA, SGMO, SUPN...",2017-07-18 00:29:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PDymc9eE7V0/gainers--losers-of-july-17-acrx-qdel-akca-sgmo-supn-20170718-00007,"Gainers & Losers Of July 17: ACRX, QDEL, AKCA, SGMO, SUPN..."
SUPN,SUPN:US,BBG000BP0HX7,"Gainers & Losers Of July 17: ACRX, QDEL, AKCA, SGMO, SUPN...",2017-07-17 23:40:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vIQ-osXIDNs/gainers--losers-of-july-17-acrx-qdel-akca-sgmo-supn-20170717-01281,"Gainers & Losers Of July 17: ACRX, QDEL, AKCA, SGMO, SUPN..."
SUPN,SUPN:US,BBG000BP0HX7,SUPN Crosses Above Average Analyst Target,2017-07-13 14:46:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/g4EcmUntJ1M/supn-crosses-above-average-analyst-target-cm815476,In recent trading shares of Supernus Pharmaceuticals Inc Symbol SUPN have crossed above the average analyst 12 month target price of 44 17 changing hands for 44 40 share When a stock reaches the target an analyst has set the analyst logically has two ways to react downgrade on
SUPN,SUPN:US,BBG000BP0HX7,"ETFs with exposure to Supernus Pharmaceuticals, Inc. : July 12, 2017",2017-07-12 18:58:54 +0000,http://finance.yahoo.com/r/75a94479-fe3b-3848-ba33-dc8207509c93/etfs-with-exposure-to-supernus-pharmaceuticals-inc-july-12-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Supernus Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to SUPN-US. Comparing the performance and risk of Supernus Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
SUPN,SUPN:US,BBG000BP0HX7,Strange: Bullish SUPN Analysts Actually See -3.33% Downside,2017-07-03 14:44:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3MN9CY7oW8k/strange-bullish-supn-analysts-actually-see-333-downside-cm811169,Analyst ratings can sometimes be complicated and we here at ETF Channel have noticed a bit of a paradox with Supernus Pharmaceuticals Inc Symbol SUPN The average 12 month price target for SUPN averaging the work of 6 analysts reveals an average price target of 41 67 share That s
SUPN,SUPN:US,BBG000BP0HX7,"ETFs with exposure to Supernus Pharmaceuticals, Inc. : June 30, 2017",2017-06-30 19:26:02 +0000,http://finance.yahoo.com/r/2bd1402d-f96b-3a01-954f-b8283d429743/etfs-with-exposure-to-supernus-pharmaceuticals-inc-june-30-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Supernus Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to SUPN-US. Comparing the performance and risk of Supernus Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
SUPN,SUPN:US,BBG000BP0HX7,3 Growth Stocks for Sharp Investors,2017-06-25 13:50:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/F9IPy7Asj5o/3-growth-stocks-for-sharp-investors-cm807830,Growth investors know that they need to be willing to act when they find a company that looks promising So which growth stocks do we think are worthy of your investment dollar today We asked a group of Fools to answer that very question and they selected Starbucks NASDAQ
SUPN,SUPN:US,BBG000BP0HX7,3 Growth Stocks for Sharp Investors,2017-06-25 11:43:00 +0000,http://finance.yahoo.com/r/5a337048-91fe-3cb9-b46b-623e4a0c8fc6/3-growth-stocks-for-sharp-investors.aspx?yptr=yahoo&.tsrc=rss,"On the hunt for a few stocks that hold upside potential? Here&apos;s why you should consider Starbucks, Wynn Resorts, and Supernus Pharmaceuticals."
SUPN,SUPN:US,BBG000BP0HX7,InPlay from Briefing.com,2017-06-21 18:56:46 +0000,https://finance.yahoo.com/news/inplay-briefing-com-125529772.html?.tsrc=rss,InPlay from Briefing.com
SUPN,SUPN:US,BBG000BP0HX7,Todd Hagopian's Top 2 Mental Health Biotech Stocks,2017-06-21 18:23:00 +0000,http://finance.yahoo.com/r/a0693153-b04e-303a-8b3c-6df5f684131e/todd-hagopians-top-2-mental-health-biotech-stocks?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix&yptr=yahoo&.tsrc=rss,"The mental health biotech sub-sector includes companies developing drugs for ADHD, depression, bipolar disorder, schizophrenia, migraines, alzheimer's, and other central nervous system conditions. Due to growing public awareness, Todd Hagopian believes these stocks are reaching a tipping point."
SUPN,SUPN:US,BBG000BP0HX7,Supernus Announces that its Partner Shire Receives FDA Approval for Mydayis™ for ADHD,2017-06-21 16:37:14 +0000,https://finance.yahoo.com/news/supernus-announces-partner-shire-receives-163714454.html?.tsrc=rss,"ROCKVILLE, Md., June 21, 2017-- Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, ..."
SUPN,SUPN:US,BBG000BP0HX7,Biotech Stock With 50% Profit Margin Nears Buy Zone,2017-06-20 15:31:24 +0000,http://finance.yahoo.com/r/10091ed6-bb82-3292-bdfa-4cfdc5ef8fa1/biotech-stock-with-50-profit-margin-nears-buy-zone?src=A00220&yptr=yahoo&.tsrc=rss,"On Tuesday, Celgene got an upgrade for its IBD SmartSelect Composite Rating from 94﻿﻿ ﻿to 97."
SUPN,SUPN:US,BBG000BP0HX7,"ETFs with exposure to Supernus Pharmaceuticals, Inc. : June 19, 2017",2017-06-19 20:09:14 +0000,http://finance.yahoo.com/r/a49b3b89-1782-38ff-b4d1-6e901a9cf843/etfs-with-exposure-to-supernus-pharmaceuticals-inc-june-19-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Supernus Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to SUPN-US. Comparing the performance and risk of Supernus Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
SUPN,SUPN:US,BBG000BP0HX7,"Supernus Pharmaceuticals, Inc. :SUPN-US: Earnings Analysis: Q1, 2017 By the Numbers : June 16, 2017",2017-06-16 15:44:18 +0000,http://finance.yahoo.com/r/2fe647f4-454a-366f-8b3a-39e94a958a5e/supernus-pharmaceuticals-inc-supn-us-earnings-analysis-q1-2017-by-the-numbers-june-16-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Supernus Pharmaceuticals, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Supernus Pharmaceuticals, Inc. – United Therapeutics Corporation, Zogenix, Inc., Alcobra Ltd., Bristol-Myers Squibb Company, Eli Lilly and Company, Shire PLC Sponsored ADR, Johnson & Johnson and Abbott Laboratories ... Read more
<b>(Read more...)</b>"
SUPN,SUPN:US,BBG000BP0HX7,Story Stocks from Briefing.com,2017-06-12 15:56:19 +0000,https://finance.yahoo.com/news/story-stocks-briefing-com-175403381.html?.tsrc=rss,Story Stocks from Briefing.com
SUPN,SUPN:US,BBG000BP0HX7,Supernus to Present at Jefferies Healthcare Conference,2017-06-01 20:22:57 +0000,https://finance.yahoo.com/news/supernus-present-jefferies-healthcare-conference-202257580.html?.tsrc=rss,"ROCKVILLE, Md., June 01, 2017-- Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, ..."
SUPN,SUPN:US,BBG000BP0HX7,This Top-Rated Biotech Just Popped To A Record High On An Upgrade,2017-06-01 20:16:49 +0000,http://finance.yahoo.com/r/c473f98b-d352-383a-8f26-c529066c8175/this-top-rated-biotech-just-popped-to-a-record-high-on-an-upgrade?src=A00220&yptr=yahoo&.tsrc=rss,"Supernus&apos; second-biggest moneymaker could grab FDA approval to treat bipolar disorder, an analyst suggested Thursday, prompting shares to a record high."
SUPN,SUPN:US,BBG000BP0HX7,Biotech And Pharma Industry And Stock News,2017-06-01 18:59:44 +0000,http://finance.yahoo.com/r/d95a9140-bcb4-38ab-b942-e0c45662051a/biotech-and-pharma-industry-and-stock-news-merk-bristol-myers-amgn-gilead?src=A00220&yptr=yahoo&.tsrc=rss,Track the latest trends and leading stocks in the biotech and pharmaceutical industries.
SUPN,SUPN:US,BBG000BP0HX7,Supernus Pharmaceuticals (SUPN) Jumps: Stock Rises 6.2%,2017-06-01 13:34:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/skCfY5hYn3Q/supernus-pharmaceuticals-supn-jumps-stock-rises-62-cm797360,Supernus Pharmaceuticals Inc SUPN was a big mover last session as its shares rose over 6 on the day The move came on solid volume too with far more shares changing hands than in a normal session This continues the recent uptrend for the company as the stock is now up roughly 12 in the
SUPN,SUPN:US,BBG000BP0HX7,Supernus Pharmaceuticals (SUPN) Jumps: Stock Rises 6.2%,2017-06-01 12:25:12 +0000,https://finance.yahoo.com/news/supernus-pharmaceuticals-supn-jumps-stock-122512989.html?.tsrc=rss,"Supernus Pharmaceuticals, Inc. (SUPN) moved big last session, as its shares jumped over 6% on the day."
SUPN,SUPN:US,BBG000BP0HX7,Today's Research Reports on Stocks to Watch: Nobilis Health Corp. and Supernus,2017-06-01 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-120000610.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / June 1, 2017 / Nobilis Health Corp. soared after a Zacks article remarked on the company's upped earnings estimates that wowed investors. Shares of Supernus Pharmaceuticals ..."
SUPN,SUPN:US,BBG000BP0HX7,"Gainers & Losers Of May 31: NDRM, CBIO, SUPN, MACK, VSTM...",2017-05-31 22:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/i5wdlTBR2xI/gainers--losers-of-may-31-ndrm-cbio-supn-mack-vstm-20170531-01508,"Gainers & Losers Of May 31: NDRM, CBIO, SUPN, MACK, VSTM..."
SUPN,SUPN:US,BBG000BP0HX7,Pharma Stock With Triple-Digit Growth Forming Blotchy Base,2017-05-24 16:12:29 +0000,http://finance.yahoo.com/r/0e418fb8-7630-3ea6-a905-2acc4feabed0/pharma-stock-with-triple-digit-growth-forming-blotchy-base?src=A00220&yptr=yahoo&.tsrc=rss,A Relative Strength Rating upgrade for Ionis Pharmaceuticals shows improving technical performance. Will it continue?
SUPN,SUPN:US,BBG000BP0HX7,Top 4 Pharmaceutical Stocks for 2017,2017-05-19 12:00:00 +0000,http://finance.yahoo.com/r/80bb33f3-0c5c-3d9d-9bf4-5580b6f76e41/pharmaceutical-stocks?partner=YahooSA&yptr=yahoo&.tsrc=rss,"Some smaller, more tightly-focused pharmaceutical stocks are outperforming the giants."
SUPN,SUPN:US,BBG000BP0HX7,Want to Get in on Biotech? Check Out These 3 Stocks,2017-05-16 14:50:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-WF7wU0S0y0/want-to-get-in-on-biotech-check-out-these-3-stocks-cm789802,Biotechnology has been one of the hottest areas for investors over the last five years due to the advent of multiple game changing new medicines and the ever expanding human population that s putting a tremendous amount of pressure on healthcare systems worldwide That said there
SUPN,SUPN:US,BBG000BP0HX7,Want to Get in on Biotech? Check Out These 3 Stocks,2017-05-16 12:32:00 +0000,http://finance.yahoo.com/r/7cb7c817-5ef6-3b87-9c6f-aeddb9d7e8f2/want-to-get-in-on-biotech-check-out-these-3-stocks.aspx?yptr=yahoo&.tsrc=rss,These three biotech equities have room to run.
SUPN,SUPN:US,BBG000BP0HX7,Edited Transcript of SUPN earnings conference call or presentation 10-May-17 1:00pm GMT,2017-05-16 07:15:58 +0000,https://finance.yahoo.com/news/edited-transcript-supn-earnings-conference-122117958.html?.tsrc=rss,Q1 2017 Supernus Pharmaceuticals Inc Earnings Call
SUPN,SUPN:US,BBG000BP0HX7,Biotech Movers: Anika Up on Strong Analyst Ratings,2017-05-12 13:50:00 +0000,http://finance.yahoo.com/r/ed59a498-b881-3b8d-b6fd-2123d87d8a22/biotech-movers-anika-up-on-strong-analyst-ratings.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Anika focuses on pain management, tissue regeneration and wound healing."
SUPN,SUPN:US,BBG000BP0HX7,"Investor Network: Supernus Pharmaceuticals, Inc. to Host Earnings Call",2017-05-10 12:30:00 +0000,http://finance.yahoo.com/news/investor-network-supernus-pharmaceuticals-inc-123000134.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / May 10, 2017 / Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN ) will be discussing their earnings results in their Q1 Earnings Call to be held May 10, 2017 at 9:00 AM Eastern ..."
SUPN,SUPN:US,BBG000BP0HX7,"ARRY Hits Trial Goals, DEPO Falls On Q1 Results, SAGE Awaits Data In Q3",2017-05-10 01:58:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Zfgxi_f0tJk/arry-hits-trial-goals-depo-falls-on-q1-results-sage-awaits-data-in-q3-20170510-00077,"ARRY Hits Trial Goals, DEPO Falls On Q1 Results, SAGE Awaits Data In Q3"
SUPN,SUPN:US,BBG000BP0HX7,Supernus misses Street 1Q forecasts,2017-05-09 20:32:54 +0000,http://finance.yahoo.com/news/supernus-misses-street-1q-forecasts-203254750.html?.tsrc=rss,"The Rockville, Maryland-based company said it had profit of 19 cents per share. The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research ..."
SUPN,SUPN:US,BBG000BP0HX7,Supernus Announces First Quarter 2017 Financial Results,2017-05-09 20:15:00 +0000,http://finance.yahoo.com/news/supernus-announces-first-quarter-2017-201500367.html?.tsrc=rss,"Net product sales were $56.4 million, a 31% increase over 2016. Operating income was $16.8 million, a 161% increase over 2016. Diluted earnings per share were $0.19, increasing by 138% over 2016. Early ..."
SUPN,SUPN:US,BBG000BP0HX7,Supernus to Host First Quarter 2017 Earnings Conference Call,2017-04-26 20:15:00 +0000,http://finance.yahoo.com/news/supernus-host-first-quarter-2017-201500615.html?.tsrc=rss,"ROCKVILLE, Md., April 26, 2017-- Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, ..."
SUPN,SUPN:US,BBG000BP0HX7,"Harry Boxer’s momentum stocks to watch: 3 biotechs, 1 retailer",2017-04-19 19:36:38 +0000,http://finance.yahoo.com/r/869100a6-ede3-3bf4-8fcf-454657e2cfb0/Story.aspx?guid=EF2B903E-2535-11E7-B1CB-9E0646962565&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Harry Boxer sums up what the charts are telling him about these four stocks.
SUPN,SUPN:US,BBG000BP0HX7,"This Biotech Leader Breaks Out, Defying Sector Odds",2017-04-18 20:45:54 +0000,http://finance.yahoo.com/r/cc889b27-bdd8-37dd-b330-c6a6efd619ad/this-biotech-leader-breaks-out-defying-sector-odds?src=A00220&yptr=yahoo&.tsrc=rss,"Shares of biotech leader Supernus Pharmaceuticals briefly broke out Tuesday, but struggled to remain above that key level of support."
SUPN,SUPN:US,BBG000BP0HX7,"Commit To Purchase Supernus Pharmaceuticals At $26, Earn 15.3% Annualized Using Options",2017-04-07 16:55:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FEuddEna4IM/commit-to-purchase-supernus-pharmaceuticals-at-26-earn-153-annualized-using-options-cm771465,Investors considering a purchase of Supernus Pharmaceuticals Inc Symbol SUPN stock but cautious about paying the going market price of 30 10 share might benefit from considering selling puts among the alternative strategies at their disposal One interesting put contract in particular is
SUPN,SUPN:US,BBG000BP0HX7,Supernus Drug Gets Label Expansion for Migraines,2017-04-06 15:58:00 +0000,http://finance.yahoo.com/r/06eb7ae1-f545-38d4-a735-6def952ed1ed/supernus-drug-gets-label-expansion-migraines-supn?partner=YahooSA&yptr=yahoo&.tsrc=rss,Supernus’ epilepsy drug Trokendi XR got FDA label expansion for use as a migraine prevention drug.
SUPN,SUPN:US,BBG000BP0HX7,"ARLZ Hands Out Pink Slips, JAZZ On A High Note, STDY On Track, TENX Abuzz",2017-04-06 01:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SmO9UTgdtvc/arlz-hands-out-pink-slips-jazz-on-a-high-note-stdy-on-track-tenx-abuzz-20170406-00018,"ARLZ Hands Out Pink Slips, JAZZ On A High Note, STDY On Track, TENX Abuzz"
SUPN,SUPN:US,BBG000BP0HX7,Supernus Receives Final FDA Approval for Trokendi XR® for Migraine Prophylaxis in Adults and Adolescents,2017-04-05 22:44:08 +0000,http://finance.yahoo.com/news/supernus-receives-final-fda-approval-224408071.html?.tsrc=rss,"ROCKVILLE, Md., April 05, 2017-- Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, ..."
SUPN,SUPN:US,BBG000BP0HX7,New 52-week Highs On Nasdaq,2017-04-03 11:26:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MZyqCEx5uzg/new-52week-highs-on-nasdaq-20170403-00937,New 52-week Highs On Nasdaq
SUPN,SUPN:US,BBG000BP0HX7,No. 5-Ranked Biotech Bolts Higher On Drug Results,2017-03-30 15:03:36 +0000,http://www.investors.com/ibd-data-stories/no-5-ranked-biotech-bolts-higher-on-drug-results/?src=A00220A,No. 5-Ranked Biotech Bolts Higher On Drug Results
SUPN,SUPN:US,BBG000BP0HX7,3 Highest Growth Stocks in the Market Today,2017-03-29 18:01:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mgF8ncZ8EAI/3-highest-growth-stocks-in-the-market-today-cm767366,Want to get in on the next great growth stock I certainly do That s why I regularly scan the markets in search of stocks that promise hyper growth I recently ran a screen on Finviz 160 to identify companies with the following characteristics Based in the
SUPN,SUPN:US,BBG000BP0HX7,3 Highest Growth Stocks in the Market Today,2017-03-29 16:06:00 +0000,http://finance.yahoo.com/r/5f2ab615-2d13-373e-b320-44cd6b10e705/3-highest-growth-stocks-in-the-market-today.aspx?yptr=yahoo&.tsrc=rss,Looking for stocks with huge upside potential? These might be worth a closer look.
SUPN,SUPN:US,BBG000BP0HX7,3 Highest Growth Stocks in the Market Today,2017-03-29 16:06:00 +0000,https://www.fool.com/investing/2017/03/29/3-highest-growth-stocks-in-the-market-today.aspx,3 Highest Growth Stocks in the Market Today
SUPN,SUPN:US,BBG000BP0HX7,Market Goes on a 'Buy the Dip' Trip,2017-03-27 17:17:00 +0000,http://realmoney.thestreet.com/articles/03/27/2017/market-goes-buy-dip-trip?puc=yahoo&cm_ven=YAHOO,[at TheStreet] - Stocks slowly recovering from early lows.
SUPN,SUPN:US,BBG000BP0HX7,There's No Rush for the Exits So Far,2017-03-27 15:10:00 +0000,http://realmoney.thestreet.com/articles/03/27/2017/theres-no-rush-exits-so-far?puc=yahoo&cm_ven=YAHOO,There's No Rush for the Exits So Far
SUPN,SUPN:US,BBG000BP0HX7,"Shark Bites: Even Without Health Care Vote, Market's Feeling Better",2017-03-24 16:25:00 +0000,http://realmoney.thestreet.com/articles/03/24/2017/shark-bites-even-without-health-care-vote-markets-feeling-better?puc=yahoo&cm_ven=YAHOO,"Shark Bites: Even Without Health Care Vote, Market's Feeling Better"
SUPN,SUPN:US,BBG000BP0HX7,SUPERNUS PHARMACEUTICALS INC Financials,2017-03-23 17:04:15 +0000,http://finance.yahoo.com/q/is?s=supn,SUPERNUS PHARMACEUTICALS INC Financials
SUPN,SUPN:US,BBG000BP0HX7,Ultragenyxs’ Seizure Drug Fails Study,2017-03-23 12:43:00 +0000,http://finance.yahoo.com/r/4d7aeeff-a0d5-38ab-a469-f16dbc38f8cf/ultragenyxs-seizure-drug-fails-study-rare-mrns?partner=YahooSA&yptr=yahoo&.tsrc=rss,"Though the drug failed in phase 2 study, Ultragenyx has announced it plans to proceed with phase 3 studies."
SUPN,SUPN:US,BBG000BP0HX7,"SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial",2017-03-09 22:00:03 +0000,http://biz.yahoo.com/e/170309/supn8-k.html,"SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial"
SUPN,SUPN:US,BBG000BP0HX7,"SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial",2017-03-08 21:47:03 +0000,http://biz.yahoo.com/e/170308/supn8-k.html,"SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial"
SUPN,SUPN:US,BBG000BP0HX7,Trump Tweet on Drug Pricing Hits Biotech and Pharma ETFs,2017-03-08 15:07:03 +0000,http://finance.yahoo.com/news/trump-tweet-drug-pricing-hits-150703468.html,Trump Tweet on Drug Pricing Hits Biotech and Pharma ETFs
SUPN,SUPN:US,BBG000BP0HX7,Supernus Pharma Tanks on Settlement of Two Patent Disputes (SUPN),2017-03-08 09:50:00 +0000,http://www.investopedia.com/news/supernus-pharma-tanks-settlement-two-patent-disputes-supn-teva/?partner=YahooSA,Supernus Pharma Tanks on Settlement of Two Patent Disputes (SUPN)
SUPN,SUPN:US,BBG000BP0HX7,Supernus Pharma Tanks on Settlement of Two Patent Disputes (SUPN),2017-03-08 09:50:00 +0000,http://finance.yahoo.com/r/1ee7e215-5943-316c-939f-4bd82eda6ac2/supernus-pharma-tanks-settlement-two-patent-disputes-supn-teva?partner=YahooSA&yptr=yahoo&.tsrc=rss,"Supernus will see generic competition for its key epilepsy drug Trokendi XR in 2023, much earlier than its patent expiry in 2027."
SUPN,SUPN:US,BBG000BP0HX7,"AXSM Looks To Busy Year Ahead, SUPN Makes Peace Again, ESPR Hits New High",2017-03-08 01:40:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fyISZgheHCg/axsm-looks-to-busy-year-ahead-supn-makes-peace-again-espr-hits-new-high-20170308-00039,"AXSM Looks To Busy Year Ahead, SUPN Makes Peace Again, ESPR Hits New High"
SUPN,SUPN:US,BBG000BP0HX7,These Pharma Stocks Are Big Losers From Trump's Drug-Pricing Tweet,2017-03-07 21:25:44 +0000,http://finance.yahoo.com/r/a64ac810-8b2d-3ba8-a406-7fb63810d8cc/supernus-valeant-endo-stocks-lose-big-after-trump-drug-pricing-tweet?src=A00220A&yptr=yahoo&.tsrc=rss,"President Trump harped on drug prices in a tweet early Tuesday, prompting generic drugmakers Teva and Mylan to dip."
SUPN,SUPN:US,BBG000BP0HX7,These Pharma Stocks Are Big Losers From Trump's Drug-Pricing Tweet,2017-03-07 21:25:44 +0000,http://www.investors.com/news/technology/supernus-valeant-endo-stocks-lose-big-after-trump-drug-pricing-tweet/?src=A00220A,These Pharma Stocks Are Big Losers From Trump's Drug-Pricing Tweet
SUPN,SUPN:US,BBG000BP0HX7,"1:08 pm Supernus Pharma announces a settlement with Teva (<a href=""/q?s=teva"" name=""teva"">TEVA</a>) subsidiary Actavis on Trokendi XR patent litigation",2017-03-07 18:08:00 +0000,http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#supn,"1:08 pm Supernus Pharma announces a settlement with Teva (<a href=""/q?s=teva"" name=""teva"">TEVA</a>) subsidiary Actavis on Trokendi XR patent litigation"
SUPN,SUPN:US,BBG000BP0HX7,Supernus Announces Settlement with Actavis on Trokendi XR® Patent Litigation,2017-03-07 18:07:14 +0000,http://finance.yahoo.com/news/supernus-announces-settlement-actavis-trokendi-180714705.html,"[GlobeNewswire] - ROCKVILLE, Md., March 07, 2017-- Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, ..."
SUPN,SUPN:US,BBG000BP0HX7,Supernus Announces Settlement with Actavis on Trokendi XR® Patent Litigation,2017-03-07 18:07:14 +0000,http://finance.yahoo.com/news/supernus-announces-settlement-actavis-trokendi-180714705.html?.tsrc=rss,"ROCKVILLE, Md., March 07, 2017-- Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, ..."
SUPN,SUPN:US,BBG000BP0HX7,"NOVN Moves Ahead, PTCT Finally Achieves It, TGTX Gets GENUINE Reaction",2017-03-07 01:18:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dzsBSqo3jPg/novn-moves-ahead-ptct-finally-achieves-it-tgtx-gets-genuine-reaction-20170307-00031,"NOVN Moves Ahead, PTCT Finally Achieves It, TGTX Gets GENUINE Reaction"
SUPN,SUPN:US,BBG000BP0HX7,Supernus Announces Settlement with Zydus on Trokendi XR® Patent Litigation,2017-03-06 22:31:05 +0000,http://finance.yahoo.com/news/supernus-announces-settlement-zydus-trokendi-223105816.html?.tsrc=rss,"ROCKVILLE, Md., March 06, 2017-- Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, ..."
SUPN,SUPN:US,BBG000BP0HX7,Supernus Announces Settlement with Zydus on Trokendi XR® Patent Litigation,2017-03-06 22:31:05 +0000,http://finance.yahoo.com/news/supernus-announces-settlement-zydus-trokendi-223105816.html,"[GlobeNewswire] - ROCKVILLE, Md., March 06, 2017-- Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, ..."
SUPN,SUPN:US,BBG000BP0HX7,"ETFs with exposure to Supernus Pharmaceuticals, Inc. : March 6, 2017",2017-03-06 19:04:49 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-supernus-pharmaceuticals-inc-march-6-2017/,"ETFs with exposure to Supernus Pharmaceuticals, Inc. : March 6, 2017"
SUPN,SUPN:US,BBG000BP0HX7,"ETFs with exposure to Supernus Pharmaceuticals, Inc. : March 6, 2017",2017-03-06 19:04:49 +0000,http://finance.yahoo.com/r/a3f2075c-9823-3f9b-a4a5-dd92fd2c03b0/etfs-with-exposure-to-supernus-pharmaceuticals-inc-march-6-2017?yptr=yahoo&.tsrc=rss,"Categories:   ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Supernus Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to SUPN-US. Comparing the performance and risk of Supernus Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more    
<b>(Read more...)</b>"
SUPN,SUPN:US,BBG000BP0HX7,"Supernus Pharmaceuticals, Inc. :SUPN-US: Earnings Analysis: Q4, 2016 By the Numbers : March 3, 2017",2017-03-03 16:30:46 +0000,http://finance.yahoo.com/r/d537217a-a98d-32e1-a5d4-e3640ccdc2b8/supernus-pharmaceuticals-inc-supn-us-earnings-analysis-q4-2016-by-the-numbers-march-3-2017?yptr=yahoo&.tsrc=rss,"Categories:   Yahoo Finance Get free summary analysis Supernus Pharmaceuticals, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Supernus Pharmaceuticals, Inc. – United Therapeutics Corporation, Alcobra Ltd., Bristol-Myers Squibb Company, Eli Lilly and Company, Shire PLC Sponsored ADR, Johnson & Johnson and Abbott Laboratories (UTHR-US, ADHD-US, ... Read more    
<b>(Read more...)</b>"
SUPN,SUPN:US,BBG000BP0HX7,"Supernus Pharmaceuticals, Inc. :SUPN-US: Earnings Analysis: Q4, 2016 By the Numbers : March 3, 2017",2017-03-03 16:30:46 +0000,http://www.capitalcube.com/blog/index.php/supernus-pharmaceuticals-inc-supn-us-earnings-analysis-q4-2016-by-the-numbers-march-3-2017/,"Supernus Pharmaceuticals, Inc. :SUPN-US: Earnings Analysis: Q4, 2016 By the Numbers : March 3, 2017"
SUPN,SUPN:US,BBG000BP0HX7,"Supernus Pharmaceuticals, Inc. :SUPN-US: Earnings Analysis: 2016 By the Numbers : March 2, 2017",2017-03-02 18:14:45 +0000,http://www.capitalcube.com/blog/index.php/supernus-pharmaceuticals-inc-supn-us-earnings-analysis-2016-by-the-numbers-march-2-2017/,"Supernus Pharmaceuticals, Inc. :SUPN-US: Earnings Analysis: 2016 By the Numbers : March 2, 2017"
SUPN,SUPN:US,BBG000BP0HX7,Edited Transcript of SUPN earnings conference call or presentation 1-Mar-17 2:00pm GMT,2017-03-01 23:45:46 +0000,http://finance.yahoo.com/news/edited-transcript-supn-earnings-conference-234546410.html?.tsrc=rss,Q4 2016 Supernus Pharmaceuticals Inc Earnings Call
SUPN,SUPN:US,BBG000BP0HX7,Edited Transcript of SUPN earnings conference call or presentation 1-Mar-17 2:00pm GMT,2017-03-01 23:45:46 +0000,http://finance.yahoo.com/news/edited-transcript-supn-earnings-conference-234546410.html,Edited Transcript of SUPN earnings conference call or presentation 1-Mar-17 2:00pm GMT
SUPN,SUPN:US,BBG000BP0HX7,Supernus Pharmaceuticals Inc Earnings Call scheduled for 9:00 am ET today,2017-03-01 14:00:00 +0000,http://biz.yahoo.com/cc/2/155952.html,Supernus Pharmaceuticals Inc Earnings Call scheduled for 9:00 am ET today
SUPN,SUPN:US,BBG000BP0HX7,"SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors o",2017-03-01 11:09:06 +0000,http://biz.yahoo.com/e/170301/supn8-k.html,"SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors o"
SUPN,SUPN:US,BBG000BP0HX7,Supernus tops Street 4Q forecasts,2017-03-01 10:02:53 +0000,http://finance.yahoo.com/news/supernus-tops-street-4q-forecasts-100253273.html?.tsrc=rss,"The Rockville, Maryland-based company said it had net income of 26 cents per share. The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research ..."
SUPN,SUPN:US,BBG000BP0HX7,Supernus tops Street 4Q forecasts,2017-03-01 10:02:53 +0000,http://sg.finance.yahoo.com/news/supernus-tops-street-4q-forecasts-100253946.html,Supernus tops Street 4Q forecasts
SUPN,SUPN:US,BBG000BP0HX7,Supernus Announces Record Fourth Quarter and Full Year 2016 Financial Results,2017-03-01 00:50:17 +0000,http://finance.yahoo.com/news/supernus-announces-record-fourth-quarter-005017371.html?.tsrc=rss,"Fourth quarter 2016 net product sales were $61.1 million, a 43% increase over 2015. Fourth quarter operating income was $16.3 million, a 107% increase over 2015. Fourth quarter diluted earnings per share ..."
SUPN,SUPN:US,BBG000BP0HX7,Supernus Announces Record Fourth Quarter and Full Year 2016 Financial Results,2017-03-01 00:50:17 +0000,http://finance.yahoo.com/news/supernus-announces-record-fourth-quarter-005017371.html,"[GlobeNewswire] - Fourth quarter 2016 net product sales were $61.1 million, a 43% increase over 2015. Fourth quarter operating income was $16.3 million, a 107% increase over 2015. Fourth quarter diluted earnings per share ..."
SUPN,SUPN:US,BBG000BP0HX7,Q4 2016 Supernus Pharmaceuticals Inc Earnings Release - After Market Close,2017-02-28 12:07:05 +0000,http://biz.yahoo.com/research/earncal/20170228.html?t=supn,Q4 2016 Supernus Pharmaceuticals Inc Earnings Release - After Market Close
SUPN,SUPN:US,BBG000BP0HX7,Supernus to Present at Cowen Health Care Conference in March,2017-02-27 21:33:55 +0000,http://finance.yahoo.com/news/supernus-present-cowen-health-care-213355141.html?.tsrc=rss,"ROCKVILLE, Md., Feb. 27, 2017-- Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, ..."
SUPN,SUPN:US,BBG000BP0HX7,Supernus to Present at Cowen Health Care Conference in March,2017-02-27 21:33:55 +0000,http://finance.yahoo.com/news/supernus-present-cowen-health-care-213355141.html,"[GlobeNewswire] - ROCKVILLE, Md., Feb. 27, 2017-- Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, ..."
SUPN,SUPN:US,BBG000BP0HX7,"Will Mylan, Glaukos, Supernus Live Up To Q4 Growth Views Next Week?",2017-02-24 22:48:23 +0000,http://www.investors.com/news/technology/will-mylan-glaukos-supernus-live-up-to-q4-growth-views-next-week/,"Will Mylan, Glaukos, Supernus Live Up To Q4 Growth Views Next Week?"
SUPN,SUPN:US,BBG000BP0HX7,"Will Mylan, Glaukos, Supernus Live Up To Q4 Growth Views Next Week?",2017-02-24 22:48:23 +0000,http://finance.yahoo.com/r/57032fcb-edf8-3d22-b427-b46e01eb2685/will-mylan-glaukos-supernus-live-up-to-q4-growth-views-next-week?yptr=yahoo&.tsrc=rss,"Mylan is expected late Wednesday to report a third consecutive quarter of sales growth, with earnings expected to re-accelerate."
SUPN,SUPN:US,BBG000BP0HX7,"SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements",2017-02-15 21:47:02 +0000,http://biz.yahoo.com/e/170215/supn8-k.html,"SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements"
SUPN,SUPN:US,BBG000BP0HX7,Supernus to Host Fourth Quarter and Full Year 2016 Earnings Conference Call,2017-02-13 21:30:00 +0000,http://finance.yahoo.com/news/supernus-host-fourth-quarter-full-213000089.html?.tsrc=rss,"ROCKVILLE, Md., Feb. 13, 2017-- Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, ..."
SUPN,SUPN:US,BBG000BP0HX7,Supernus to Host Fourth Quarter and Full Year 2016 Earnings Conference Call,2017-02-13 21:30:00 +0000,http://finance.yahoo.com/news/supernus-host-fourth-quarter-full-213000089.html,"[GlobeNewswire] - ROCKVILLE, Md., Feb. 13, 2017-- Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, ..."
SUPN,SUPN:US,BBG000BP0HX7,"SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2017-02-10 21:35:09 +0000,http://biz.yahoo.com/e/170210/supn8-k.html,"SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
SUPN,SUPN:US,BBG000BP0HX7,Supernus Announces Issuance of Eighth U.S. Patent Protecting Trokendi XR®,2017-02-08 12:00:00 +0000,http://finance.yahoo.com/news/supernus-announces-issuance-eighth-u-120000689.html?.tsrc=rss,"ROCKVILLE, Md., Feb. 08, 2017-- Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, ..."
SUPN,SUPN:US,BBG000BP0HX7,Supernus Announces Issuance of Eighth U.S. Patent Protecting Trokendi XR®,2017-02-08 12:00:00 +0000,http://finance.yahoo.com/news/supernus-announces-issuance-eighth-u-120000689.html,"[GlobeNewswire] - ROCKVILLE, Md., Feb. 08, 2017-- Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, ..."
SUPN,SUPN:US,BBG000BP0HX7,Top 4 Pharmaceutical Stocks for 2017,2017-01-30 18:00:00 +0000,http://finance.yahoo.com/r/1c4eba87-50f8-3e8a-bdd3-6b4ae091385c/pharmaceutical-stocks?partner=YahooSA&yptr=yahoo&.tsrc=rss,"Some smaller, more tightly-focused pharmaceutical stocks are outperforming the giants."
SUPN,SUPN:US,BBG000BP0HX7,Supernus Announces Issuance of Seventh U.S. Patent Protecting Trokendi XR®,2017-01-30 12:00:00 +0000,http://finance.yahoo.com/news/supernus-announces-issuance-seventh-u-120000813.html?.tsrc=rss,"ROCKVILLE, Md., Jan. 30, 2017-- Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, ..."
SUPN,SUPN:US,BBG000BP0HX7,Supernus Announces Issuance of Seventh U.S. Patent Protecting Trokendi XR®,2017-01-30 12:00:00 +0000,http://finance.yahoo.com/news/supernus-announces-issuance-seventh-u-120000813.html,"[GlobeNewswire] - ROCKVILLE, Md., Jan. 30, 2017-- Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, ..."
SUPN,SUPN:US,BBG000BP0HX7,"HealthInvest Partners AB Buys Gilead Sciences Inc, McKesson Corp, Syneron Medical Ltd, Sells ...",2017-01-25 09:30:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/weMrXCxuBhU/healthinvest-partners-ab-buys-gilead-sciences-inc-mckesson-corp-syneron-medical-ltd-sells-cm737753,HealthInvest Partners AB New Purchases GILD MCK ELOS ATEC Reduced Positions ANIK GNC MRK ANTM ABC GTS CAH CRL SUPN TARO Sold Out AMAG LPNT CXRX INCR INSY OSUR New Purchases GILD MCK ELOS ATEC New
SUPN,SUPN:US,BBG000BP0HX7,"Greater Washington's fastest-growing company forced to lower earnings, income for two years",2017-01-24 20:17:07 +0000,http://www.bizjournals.com/washington/news/2017/01/24/greater-washingtons-fastest-growing-company-has-to.html?ana=yahoo,"Greater Washington's fastest-growing company forced to lower earnings, income for two years"
SUPN,SUPN:US,BBG000BP0HX7,"Greater Washington's fastest-growing company forced to lower earnings, income for two years",2017-01-24 20:17:07 +0000,http://finance.yahoo.com/r/21dfcf02-e40c-3372-ac1e-ff5d647e6e6b/greater-washingtons-fastest-growing-company-has-to.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Greater Washington's fastest-growing company in 2015 did not grow quite as fast as it initially reported.  In a filing with the U.S. Securities and Exchange Commission , Rockville-based Supernus Pharmaceuticals Inc. said it revised 2014 and 2015 revenue and earnings downward because it incorrectly counted $30 million in future drug royalties from a 2014 transaction as revenue.  The company, which specializes in creating therapies for central nervous system diseases, said its former auditor alerted it in August to an SEC ruling in a similar royalty case that might affect its own financial statements."
SUPN,SUPN:US,BBG000BP0HX7,"Company News for January 24, 2017",2017-01-24 17:34:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/lmNrcL9TXyk/company-news-for-january-24-2017-cm737441,Shares of Community Bank System Inc CBU increased 1 1 after posting fourth quarter earnings of 0 61 per share beating the Zacks Consensus Estimate by 3 cents Supernus Pharmaceuticals Inc s SUPN shares advanced 1 9 after announcing fiscal third quarter earnings per
SUPN,SUPN:US,BBG000BP0HX7,"Company News for January 24, 2017",2017-01-24 15:10:03 +0000,http://finance.yahoo.com/news/company-news-january-24-2017-151003910.html,"Company News for January 24, 2017"
SUPN,SUPN:US,BBG000BP0HX7,"SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits",2017-01-23 21:39:29 +0000,http://biz.yahoo.com/e/170123/supn8-k.html,"SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits"
SUPN,SUPN:US,BBG000BP0HX7,"Supernus Pharmaceuticals, Inc. – Value Analysis (NASDAQ:SUPN) : January 23, 2017",2017-01-23 17:26:30 +0000,http://www.capitalcube.com/blog/index.php/supernus-pharmaceuticals-inc-value-analysis-nasdaqsupn-january-23-2017/,"Supernus Pharmaceuticals, Inc. – Value Analysis (NASDAQ:SUPN) : January 23, 2017"
SUPN,SUPN:US,BBG000BP0HX7,Supernus Files Form 10-Q for Third Quarter 2016 and Is Now Current with All Financial Filings,2017-01-23 16:13:53 +0000,http://finance.yahoo.com/news/supernus-files-form-10-q-161353865.html,"[GlobeNewswire] - ROCKVILLE, Md., Jan. 23, 2017-- Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, ..."
SUPN,SUPN:US,BBG000BP0HX7,"SUPERNUS PHARMACEUTICALS INC Files SEC form 10-Q/A, Quarterly Report",2017-01-23 11:03:46 +0000,http://biz.yahoo.com/e/170123/supn10-q_a.html,"SUPERNUS PHARMACEUTICALS INC Files SEC form 10-Q/A, Quarterly Report"
SUPN,SUPN:US,BBG000BP0HX7,Supernus misses 3Q revenue forecasts,2017-01-21 00:14:35 +0000,http://sg.finance.yahoo.com/news/supernus-misses-3q-revenue-forecasts-001435771.html,Supernus misses 3Q revenue forecasts
SUPN,SUPN:US,BBG000BP0HX7,"SUPERNUS PHARMACEUTICALS INC Files SEC form 10-Q/A, Quarterly Report",2017-01-20 22:31:06 +0000,http://biz.yahoo.com/e/170120/supn10-q_a.html,"SUPERNUS PHARMACEUTICALS INC Files SEC form 10-Q/A, Quarterly Report"
SUPN,SUPN:US,BBG000BP0HX7,"Supernus Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : SUPN-US : January 20, 2017",2017-01-20 13:32:49 +0000,http://www.capitalcube.com/blog/index.php/supernus-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bearish-manner-supn-us-january-20-2017/,"Supernus Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : SUPN-US : January 20, 2017"
SUPN,SUPN:US,BBG000BP0HX7,Q4 Earnings Preview: Stocks Expecting 50% Or Higher Growth,2017-01-15 19:10:49 +0000,http://www.investors.com/news/q4-earnings-preview-stocks-expecting-50-or-higher-growth-nvidia-morgan-stanley/,Q4 Earnings Preview: Stocks Expecting 50% Or Higher Growth
SUPN,SUPN:US,BBG000BP0HX7,"SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2017-01-06 21:44:43 +0000,http://biz.yahoo.com/e/170106/supn8-k.html,"SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
SUPN,SUPN:US,BBG000BP0HX7,Supernus to Present at the 2017 J.P. Morgan Healthcare Conference,2017-01-03 21:30:00 +0000,http://finance.yahoo.com/news/supernus-present-2017-j-p-213000968.html,"[GlobeNewswire] - ROCKVILLE, Md., Jan. 03, 2017-- Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, ..."
SUPN,SUPN:US,BBG000BP0HX7,"Commit To Buy Supernus Pharmaceuticals At $20, Earn 10.7% Annualized Using Options",2016-12-28 17:57:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/07D2f5s3udg/commit-to-buy-supernus-pharmaceuticals-at-20-earn-107-annualized-using-options-cm727017,Investors considering a purchase of Supernus Pharmaceuticals Inc Symbol SUPN stock but tentative about paying the going market price of 25 70 share might benefit from considering selling puts among the alternative strategies at their disposal One interesting put contract in particular
SUPN,SUPN:US,BBG000BP0HX7,4 stocks to watch,2016-12-21 20:26:44 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=C4110C24-E519-47CB-B5BF-ECF53AE20878&siteid=yhoof2,4 stocks to watch
SUPN,SUPN:US,BBG000BP0HX7,"The Bulls Don't Have Enough Juice for 20,000",2016-12-20 15:44:00 +0000,http://realmoney.thestreet.com/articles/12/20/2016/bulls-dont-have-enough-juice-20000?puc=yahoo&cm_ven=YAHOO,"The Bulls Don't Have Enough Juice for 20,000"
SUPN,SUPN:US,BBG000BP0HX7,"This Marijuana Stock Is Up 1,187% -- Is There More Room to Run?",2016-12-20 00:57:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TgdHDVBs4eQ/this-marijuana-stock-is-up-1187-is-there-more-room-to-run-cm723669,Shares in marijuana medicine maker GW Pharmaceuticals plc NASDAQ GWPH have been on a tear From the end of May 2013 when the company s shares first began trading on the Nasdaq through Friday its shares have skyrocketed 1 187 For perspective a 10 000 investment in
SUPN,SUPN:US,BBG000BP0HX7,"This Marijuana Stock Is Up 1,187% -- Is There More Room to Run?",2016-12-19 23:00:06 +0000,http://www.fool.com/investing/2016/12/19/this-marijuana-stock-is-up-1187-is-there-more-room.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"This Marijuana Stock Is Up 1,187% -- Is There More Room to Run?"
SUPN,SUPN:US,BBG000BP0HX7,Supernus Pharmaceuticals Breaks Out On Up Day For Biotech Stocks,2016-12-19 21:16:15 +0000,http://www.investors.com/news/technology/supernus-pharmaceuticls-breaks-out-on-up-day-for-biotech-stocks/,Supernus Pharmaceuticals Breaks Out On Up Day For Biotech Stocks
SUPN,SUPN:US,BBG000BP0HX7,Stocks Higher As 3 Medicals Hit Buy Points; No 'Star Wars' Hasbro Bump,2016-12-19 18:48:48 +0000,http://www.investors.com/market-trend/stock-market-today/stocks-higher-as-3-top-medical-stocks-hit-buy-points-no-star-wars-bump-for-hasbro/,Stocks Higher As 3 Medicals Hit Buy Points; No 'Star Wars' Hasbro Bump
SUPN,SUPN:US,BBG000BP0HX7,Is Precision Drilling Corp (USA) (PDS) A Good Stock To Buy?,2016-12-19 02:32:49 +0000,http://www.insidermonkey.com/blog/is-precision-drilling-corp-usa-pds-a-good-stock-to-buy-509337/,Is Precision Drilling Corp (USA) (PDS) A Good Stock To Buy?
SUPN,SUPN:US,BBG000BP0HX7,"SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2016-12-15 21:32:58 +0000,http://biz.yahoo.com/e/161215/supn8-k.html,"SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
SUPN,SUPN:US,BBG000BP0HX7,Supernus Wins Appeal Case on Oxtellar XR®,2016-12-12 21:30:00 +0000,http://finance.yahoo.com/news/supernus-wins-appeal-case-oxtellar-213000257.html,"[GlobeNewswire] - ROCKVILLE, Md., Dec. 12, 2016-- Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, ..."
SUPN,SUPN:US,BBG000BP0HX7,Hedge Funds Are Crazy About Supernus Pharmaceuticals Inc (SUPN),2016-12-02 07:24:55 +0000,http://www.insidermonkey.com/blog/hedge-funds-are-crazy-about-supernus-pharmaceuticals-inc-supn-496520/,Hedge Funds Are Crazy About Supernus Pharmaceuticals Inc (SUPN)
SUPN,SUPN:US,BBG000BP0HX7,"ETFs with exposure to Supernus Pharmaceuticals, Inc. : November 29, 2016",2016-11-29 19:24:25 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-supernus-pharmaceuticals-inc-november-29-2016/,"ETFs with exposure to Supernus Pharmaceuticals, Inc. : November 29, 2016"
SUPN,SUPN:US,BBG000BP0HX7,What's in the Cards for Nutanix (NTNX) in Q1 Earnings?,2016-11-28 23:54:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/d6-nXc_ukLY/whats-in-the-cards-for-nutanix-ntnx-in-q1-earnings-cm714799,Nutanix Inc NTNX is set to report its first quarter fiscal 2017 earnings on Nov 29 2016 This will be the company s first earnings call since it went public on Sep 30 The enterprise cloud platform provider raised almost 238 million by selling 14 87 million shares at a price of 16 00
SUPN,SUPN:US,BBG000BP0HX7,Top Ranked Income Stocks to Buy for November 28th,2016-11-28 17:32:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/36xf0Apt2qc/top-ranked-income-stocks-to-buy-for-november-28th-cm714552,Here are four stocks that are likely to beat earnings for the week of November 28 th Supernus Pharmaceuticals Inc SUPN This specialty pharmaceutical company has witnessed the Zacks Consensus Estimate for its current year earnings surging 15 4 over the last 30 days SUPERNUS
SUPN,SUPN:US,BBG000BP0HX7,"What's in the Cards for Box, Inc. (BOX) in Q3 Earnings?",2016-11-28 14:34:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SxNM6QAYu4E/whats-in-the-cards-for-box-inc-box-in-q3-earnings-cm714375,Box Inc BOX is set to report third quarter fiscal 2017 results on Nov 30 Last quarter the company posted a positive earnings surprise of 21 62 Let s see how things are shaping up for this announcement Factors at Play Box incurred fiscal second quarter loss of 29 cents per
SUPN,SUPN:US,BBG000BP0HX7,Top Ranked Income Stocks to Buy for November 28th,2016-11-28 13:58:01 +0000,http://finance.yahoo.com/news/top-ranked-income-stocks-buy-135801125.html,Top Ranked Income Stocks to Buy for November 28th
SUPN,SUPN:US,BBG000BP0HX7,"Supernus Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : SUPN-US : November 28, 2016",2016-11-28 12:18:28 +0000,http://www.capitalcube.com/blog/index.php/supernus-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bullish-manner-supn-us-november-28-2016/,"Supernus Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : SUPN-US : November 28, 2016"
SUPN,SUPN:US,BBG000BP0HX7,Is Mallinckrodt (MNK) Poised for a Beat in Q4 Earnings?,2016-11-23 16:07:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MYx9k-cODgI/is-mallinckrodt-mnk-poised-for-a-beat-in-q4-earnings-cm713271,Mallinckrodt plc MNK is set to report fourth quarter fiscal 2016 results on Nov 29 The company s track has been impressive so far It has beaten estimates in each of the last four quarters with a positive average earnings surprise of 11 9 Let s see how things are shaping up for
SUPN,SUPN:US,BBG000BP0HX7,Why Earnings Season Could Be Great for Supernus (SUPN),2016-11-21 18:13:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fVd2vbMAyl0/why-earnings-season-could-be-great-for-supernus-supn-cm712107,Investors are always looking for stocks that are poised to beat at earnings season and Supernus Pharmaceuticals Inc SUPN may be one such company The firm has earnings coming up pretty soon and events are shaping up quite nicely for their report That is because Supernus is
SUPN,SUPN:US,BBG000BP0HX7,Why Earnings Season Could Be Great for Supernus (SUPN),2016-11-21 15:39:03 +0000,http://finance.yahoo.com/news/why-earnings-season-could-great-153903624.html,Why Earnings Season Could Be Great for Supernus (SUPN)
SUPN,SUPN:US,BBG000BP0HX7,Will Q3 Earnings Hold a Surprise for SeaDrill (SDRL) Stock?,2016-11-18 23:50:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MiWgOBB94zY/will-q3-earnings-hold-a-surprise-for-seadrill-sdrl-stock-cm711514,Leading contract driller SeaDrill Ltd SDRL is set to release its third quarter 2016 results on Tuesday Nov 22 In the preceding three month period the company delivered a positive earnings surprise of 43 90 due to lower operating expenses In terms of earnings surprise history SeaDrill
SUPN,SUPN:US,BBG000BP0HX7,"SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule o",2016-11-18 21:17:22 +0000,http://biz.yahoo.com/e/161118/supn8-k.html,"SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule o"
SUPN,SUPN:US,BBG000BP0HX7,Will Q3 Earnings Hold a Surprise for SeaDrill (SDRL) Stock?,2016-11-18 21:17:09 +0000,http://finance.yahoo.com/news/q3-earnings-hold-surprise-seadrill-211709388.html,Will Q3 Earnings Hold a Surprise for SeaDrill (SDRL) Stock?
SUPN,SUPN:US,BBG000BP0HX7,"BSTC Finds New Use For Old Drug, FHCO Gets A Boost, SUPN Put On Notice",2016-11-18 01:13:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PRU6Fgpgv10/bstc-finds-new-use-for-old-drug-fhco-gets-a-boost-supn-put-on-notice-20161118-00017,"BSTC Finds New Use For Old Drug, FHCO Gets A Boost, SUPN Put On Notice"
SUPN,SUPN:US,BBG000BP0HX7,Supernus Receives Nasdaq Non-Compliance Notice,2016-11-17 21:58:12 +0000,http://www.publicnow.com/view/2B17A8C81224E40167AB1290BAC604369F4B8134,"[at noodls] - ROCKVILLE, Md., Nov. 17, 2016 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of ..."
SUPN,SUPN:US,BBG000BP0HX7,"ETFs with exposure to Supernus Pharmaceuticals, Inc. : November 16, 2016",2016-11-16 17:15:55 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-supernus-pharmaceuticals-inc-november-16-2016/,"ETFs with exposure to Supernus Pharmaceuticals, Inc. : November 16, 2016"
SUPN,SUPN:US,BBG000BP0HX7,"Supernus Pharmaceuticals, Inc.: Leads amongst peers with strong fundamentals",2016-11-15 20:29:19 +0000,http://www.capitalcube.com/blog/index.php/supernus-pharmaceuticals-inc-leads-amongst-peers-with-strong-fundamentals/,"Supernus Pharmaceuticals, Inc.: Leads amongst peers with strong fundamentals"
SUPN,SUPN:US,BBG000BP0HX7,"Supernus Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : SUPN-US : November 15, 2016",2016-11-15 12:36:04 +0000,http://www.capitalcube.com/blog/index.php/supernus-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bullish-manner-supn-us-november-15-2016/,"Supernus Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : SUPN-US : November 15, 2016"
SUPN,SUPN:US,BBG000BP0HX7,"Supernus, Puma Among 5 Biotech Stock Winners, Losers Monday",2016-11-14 21:02:19 +0000,http://www.investors.com/news/technology/supernus-puma-among-5-biotech-stock-winners-losers-monday/,"Supernus, Puma Among 5 Biotech Stock Winners, Losers Monday"
SUPN,SUPN:US,BBG000BP0HX7,Supernus Provides Business Update,2016-11-14 13:37:06 +0000,http://www.publicnow.com/view/2D6743F8A6A79A6B9F31A380B3F6C10C049EC05F,"[at noodls] - ROCKVILLE, Md., Nov. 14, 2016 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of ..."
SUPN,SUPN:US,BBG000BP0HX7,"SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Non-Reliance on Previous Financials, Audits or Interim Review, Other",2016-11-14 11:16:43 +0000,http://biz.yahoo.com/e/161114/supn8-k.html,"SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Non-Reliance on Previous Financials, Audits or Interim Review, Other"
SUPN,SUPN:US,BBG000BP0HX7,Supernus to Host a Business Update Call,2016-11-11 18:17:12 +0000,http://www.publicnow.com/view/66574227DED15C9E06101EA5BECF22418EACEAB8,"[at noodls] - ROCKVILLE, Md., Nov. 11, 2016 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of ..."
SUPN,SUPN:US,BBG000BP0HX7,Supernus to Present at Three November Healthcare Conferences,2016-11-07 18:30:00 +0000,http://finance.yahoo.com/news/supernus-present-three-november-healthcare-183000688.html,"[GlobeNewswire] - ROCKVILLE, Md., Nov. 07, 2016-- Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, ..."
SUPN,SUPN:US,BBG000BP0HX7,"SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2016-10-14 20:17:33 +0000,http://biz.yahoo.com/e/161014/supn8-k.html,"SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
SUPN,SUPN:US,BBG000BP0HX7,Supernus (SUPN) Reports Encouraging Data from ADHD Study,2016-10-13 20:41:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nhX0tPVIZPg/supernus-supn-reports-encouraging-data-from-adhd-study-cm693138,Supernus Pharmaceuticals Inc SUPN announced encouraging top line data from a phase IIb dose ranging study n 222 on one of its lead pipeline candidate SPN 812 for the treatment of attention deficit hyperactivity disorder ADHD in children SPN 812 is being developed as a novel non
SUPN,SUPN:US,BBG000BP0HX7,Supernus (SUPN) Reports Encouraging Data from ADHD Study,2016-10-13 18:25:06 +0000,http://finance.yahoo.com/news/supernus-supn-reports-encouraging-data-182506855.html,Supernus (SUPN) Reports Encouraging Data from ADHD Study
SUPN,SUPN:US,BBG000BP0HX7,"Biotechs Worst-Performing Stocks Wednesday; Prothena, Supernus Fall",2016-10-12 20:22:01 +0000,http://www.investors.com/news/technology/biotechs-worst-performing-stocks-wednesday-prothena-supernus-fall/,"Biotechs Worst-Performing Stocks Wednesday; Prothena, Supernus Fall"
SUPN,SUPN:US,BBG000BP0HX7,Supernus ADHD Drug Trial Shows Good Results (SUPN),2016-10-12 16:56:00 +0000,http://www.investopedia.com/news/supernus-makes-progress-adhd-drug-supn/?partner=YahooSA,Supernus ADHD Drug Trial Shows Good Results (SUPN)
SUPN,SUPN:US,BBG000BP0HX7,Blog Coverage Supernus Reports Positive Results from Phase IIb Clinical Trial for SPN 812,2016-10-12 13:10:50 +0000,http://news.investornetwork.com/2016/10/12/blog-coverage-supernus-reports-positive-results-from-phase-iib-clinical-trial-for-spn-812/?1=1&1476277850,Blog Coverage Supernus Reports Positive Results from Phase IIb Clinical Trial for SPN 812
SUPN,SUPN:US,BBG000BP0HX7,"Supernus Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : SUPN-US : October 12, 2016",2016-10-12 12:46:30 +0000,http://www.capitalcube.com/blog/index.php/supernus-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bearish-manner-supn-us-october-12-2016/,"Supernus Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : SUPN-US : October 12, 2016"
SUPN,SUPN:US,BBG000BP0HX7,"IPCI Continues To Move Up, NBIX To Face FDA In April, Good Tidings From NYMX",2016-10-12 02:14:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/p9xVzYcCTNE/ipci-continues-to-move-up-nbix-to-face-fda-in-april-good-tidings-from-nymx-20161012-00026,"IPCI Continues To Move Up, NBIX To Face FDA In April, Good Tidings From NYMX"
SUPN,SUPN:US,BBG000BP0HX7,Supernus Pharmaceuticals Inc (SUPN) Stock Dips Despite Positive ADHD Data,2016-10-11 23:19:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/w8QljlhCx50/supernus-pharmaceuticals-inc-supn-stock-dips-despite-positive-adhd-data-cm692000,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Supernus Pharmaceuticals Inc NASDAQ SUPN spiked 2 out of the gate before profit takers immediately seized upon the opportunity and brought SUPN stock down
SUPN,SUPN:US,BBG000BP0HX7,Supernus Stock Reverses Downward Despite Good ADHD Drug Trial,2016-10-11 20:31:15 +0000,http://www.investors.com/news/technology/supernus-stock-reverses-near-breakout-despite-adhd-drug-win/,Supernus Stock Reverses Downward Despite Good ADHD Drug Trial
SUPN,SUPN:US,BBG000BP0HX7,"Amazon.com, Inc. (AMZN) vs. JD.Com (JD) – Which Is the Better Growth Stock?",2016-10-11 19:19:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pa7wVHqoots/amazoncom-inc-amzn-vs-jdcom-jd-which-is-the-better-growth-stock-cm691994,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips For online retail 160 investors there are two main questions Do you want to own Amazon com Inc 160 NASDAQ AMZN 160 stock or one of its competitors After all AMZN remains the
SUPN,SUPN:US,BBG000BP0HX7,"Nasdaq Leads Sharp Losses As Fiber Optics, Medicals Slide; Biogen Off 2%",2016-10-11 19:06:11 +0000,http://www.investors.com/market-trend/stock-market-today/nasdaq-leads-sharp-losses-as-fiber-optics-medicals-slide-biogen-off-2/,"Nasdaq Leads Sharp Losses As Fiber Optics, Medicals Slide; Biogen Off 2%"
SUPN,SUPN:US,BBG000BP0HX7,"Here’s Why Supernus Pharmaceuticals, Rent-A-Center and Three Other Stocks are Down Today",2016-10-11 17:08:38 +0000,http://www.insidermonkey.com/blog/heres-why-supernus-pharmaceuticals-rent-a-center-and-three-other-stocks-are-down-today-480390/,"Here’s Why Supernus Pharmaceuticals, Rent-A-Center and Three Other Stocks are Down Today"
SUPN,SUPN:US,BBG000BP0HX7,"Pre-Market Most Active for Oct 11, 2016 :  AAPL, STJ, ABT, TWTR, MT, ILMN, TVIX, BCS, ABX, SUPN, SQQQ, QQQ",2016-10-11 12:57:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aRUfatgmDW8/pre-market-most-active-for-oct-11-2016-aapl-stj-abt-twtr-mt-ilmn-tvix-bcs-abx-supn-sqqq-qqq-cm691471,The NASDAQ 100 Pre Market Indicator is up 3 98 to 4 897 75 The total Pre Market volume is currently 6 466 895 shares traded The following are the most active stocks for the pre market session Apple Inc AAPL is 2 13 at 118 18 with 1 863 628 shares traded As
SUPN,SUPN:US,BBG000BP0HX7,Supernus Announces Positive Results from Phase IIb Clinical Trial For SPN-812 in Children with ADHD,2016-10-11 12:09:02 +0000,http://www.publicnow.com/view/56E463C59E7931B637F792AA65983150B52DF031,"[at noodls] - Study confirms efficacy and tolerability of SPN-812, a novel non-stimulant product, in children with ADHD Study meets primary endpoint with statistically significant reduction in ADHD symptoms Conference ..."
SUPN,SUPN:US,BBG000BP0HX7,"ILMN Fails To Light Up, MDGN Leaves The Big Board For Nasdaq, Watch Out For SUPN",2016-10-11 00:37:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fF--YSyNObw/ilmn-fails-to-light-up-mdgn-leaves-the-big-board-for-nasdaq-watch-out-for-supn-20161011-00038,"ILMN Fails To Light Up, MDGN Leaves The Big Board For Nasdaq, Watch Out For SUPN"
SUPN,SUPN:US,BBG000BP0HX7,Supernus Schedules Conference Call to Present Results of Phase IIb Clinical Trial of SPN-812 in Children with ADHD,2016-10-10 20:30:00 +0000,http://finance.yahoo.com/news/supernus-schedules-conference-call-present-203000352.html,"[GlobeNewswire] - ROCKVILLE, Md., Oct. 10, 2016-- Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, ..."
SUPN,SUPN:US,BBG000BP0HX7,"The Zacks Analyst Blog Highlights: GW Pharmaceuticals, Shire, Johnson & Johnson and Supernus Pharmaceuticals",2016-10-10 15:21:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sHtAHgYKFNg/the-zacks-analyst-blog-highlights-gw-pharmaceuticals-shire-johnson-johnson-and-supernus-pharmaceuticals-cm690999,For Immediate Release Chicago IL October 10 2016 Zacks com announces the list of stocks featured in the Analyst Blog Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets Stocks recently featured in the blog
SUPN,SUPN:US,BBG000BP0HX7,"The Zacks Analyst Blog Highlights: GW Pharmaceuticals, Shire, Johnson & Johnson and Supernus Pharmaceuticals",2016-10-10 13:30:01 +0000,http://finance.yahoo.com/news/zacks-analyst-blog-highlights-gw-133001576.html,"The Zacks Analyst Blog Highlights: GW Pharmaceuticals, Shire, Johnson & Johnson and Supernus Pharmaceuticals"
SUPN,SUPN:US,BBG000BP0HX7,These Are the Fastest Growing Profitable Biotech Stocks,2016-10-07 15:46:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZDqgJDaRWOE/these-are-the-fastest-growing-profitable-biotech-stocks-cm690342,Image source Getty Images The biotech industry could be described as the stock market s roulette wheel While nearly 90 of all biotech stocks are losing money and the vast majority of clinical trials will end in failure a clinical win could result in investors getting a return
SUPN,SUPN:US,BBG000BP0HX7,5 Stock Picks Ahead of World Mental Health Day,2016-10-07 15:46:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NFC9-1yOqfM/5-stock-picks-ahead-of-world-mental-health-day-cm690306,World Mental Health Day is observed every year on Oct 10 this year the theme is psychological first aid which covers both psychological and social support According to information provided by the National Alliance on Mental Illness about one in five adults in the U S or 43 8
SUPN,SUPN:US,BBG000BP0HX7,These Are the Fastest Growing Profitable Biotech Stocks,2016-10-07 14:12:36 +0000,http://www.fool.com/investing/2016/10/07/these-are-the-fastest-growing-profitable-biotech-s.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,These Are the Fastest Growing Profitable Biotech Stocks
SUPN,SUPN:US,BBG000BP0HX7,5 Stock Picks Ahead of World Mental Health Day,2016-10-07 13:57:01 +0000,http://finance.yahoo.com/news/5-stock-picks-ahead-world-135701600.html,5 Stock Picks Ahead of World Mental Health Day
SUPN,SUPN:US,BBG000BP0HX7,"ETF’s with exposure to Supernus Pharmaceuticals, Inc. : September 30, 2016",2016-09-30 14:09:08 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-supernus-pharmaceuticals-inc-september-30-2016/,"ETF’s with exposure to Supernus Pharmaceuticals, Inc. : September 30, 2016"
SUPN,SUPN:US,BBG000BP0HX7,"Thursday's ETF Movers: OIH, XPH",2016-09-29 18:21:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oNu0ODTdavE/thursdays-etf-movers-oih-xph-cm686697,In trading on Thursday the Oil Services ETF is outperforming other ETFs up about 4 on the day Components of that ETF showing particular strength include shares of Superior Energy Services up about 9 1 and shares of Transocean up about 8 on the day And underperforming other ETFs
SUPN,SUPN:US,BBG000BP0HX7,Stocks Close Barely Higher Ahead Of Fed Announcement; Biotechs Aid Nasdaq,2016-09-20 19:01:44 +0000,http://www.investors.com/market-trend/stock-market-today/stocks-higher-ahead-of-fed-surging-biotechs-give-nasdaq-a-boost/,Stocks Close Barely Higher Ahead Of Fed Announcement; Biotechs Aid Nasdaq
SUPN,SUPN:US,BBG000BP0HX7,Stocks Hold Modest Gains Near Midday; Biotechs Strong Again,2016-09-20 16:08:53 +0000,http://www.investors.com/market-trend/stock-market-today/stocks-hold-modest-gains-near-midday-biotechs-strong-again/,Stocks Hold Modest Gains Near Midday; Biotechs Strong Again
SUPN,SUPN:US,BBG000BP0HX7,Nasdaq Erases Gains But Small Caps Strong Ahead Of Fed,2016-09-19 17:14:39 +0000,http://www.investors.com/market-trend/stock-market-today/stocks-rise-small-caps-chips-lead-as-wall-street-awaits-fed/,Nasdaq Erases Gains But Small Caps Strong Ahead Of Fed
SUPN,SUPN:US,BBG000BP0HX7,Seeing the Same Old Patterns Ahead of Fed News,2016-09-19 14:55:00 +0000,http://realmoney.thestreet.com/articles/09/19/2016/seeing-same-old-patterns-ahead-fed-news?puc=yahoo&cm_ven=YAHOO,Seeing the Same Old Patterns Ahead of Fed News
SUPN,SUPN:US,BBG000BP0HX7,"Stocks Red But On Track For Weekly Gains; Intel, UnitedHealth Lead Dow",2016-09-16 19:02:42 +0000,http://www.investors.com/market-trend/stock-market-today/stocks-red-but-on-track-for-weekly-gains-intel-unitedhealth-lead-dow/,"Stocks Red But On Track For Weekly Gains; Intel, UnitedHealth Lead Dow"
SUPN,SUPN:US,BBG000BP0HX7,"Indexes Lower But Amazon, Some Health Care Stocks Rise",2016-09-16 18:00:15 +0000,http://www.investors.com/market-trend/stock-market-today/indexes-lower-but-amazon-some-health-care-stocks-rise/,"Indexes Lower But Amazon, Some Health Care Stocks Rise"
SUPN,SUPN:US,BBG000BP0HX7,Shark Bites: 5 Stocks I Am Playing in This Choppy Action,2016-09-16 15:57:00 +0000,http://realmoney.thestreet.com/articles/09/16/2016/shark-bites-5-stocks-i-am-playing-choppy-action?puc=yahoo&cm_ven=YAHOO,Shark Bites: 5 Stocks I Am Playing in This Choppy Action
SUPN,SUPN:US,BBG000BP0HX7,"ETF’s with exposure to Supernus Pharmaceuticals, Inc. : September 15, 2016",2016-09-15 14:45:20 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-supernus-pharmaceuticals-inc-september-15-2016/,"ETF’s with exposure to Supernus Pharmaceuticals, Inc. : September 15, 2016"
SUPN,SUPN:US,BBG000BP0HX7,"Supernus Pharmaceuticals, Inc. – Value Analysis (NASDAQ:SUPN) : September 13, 2016",2016-09-13 15:56:20 +0000,http://www.capitalcube.com/blog/index.php/supernus-pharmaceuticals-inc-value-analysis-nasdaqsupn-september-13-2016/,"Supernus Pharmaceuticals, Inc. – Value Analysis (NASDAQ:SUPN) : September 13, 2016"
SUPN,SUPN:US,BBG000BP0HX7,4 Momentum Stocks to Watch,2016-09-13 15:12:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dZFdV7kL0Sg/4-momentum-stocks-to-watch-cm678803,"By Harry Boxer   These four stocks have strong technical momentum.   Clovis Oncology, Inc.  ( CLVS ), which poppped nearly 30% three weeks ago and then flagged, broke out of the flag last week and looks to be consolidating ahead of its next up-move.  On Monday it gained 40 cents to 28.05 on strong volume of 2.8"
SUPN,SUPN:US,BBG000BP0HX7,"Supernus Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : SUPN-US : September 12, 2016",2016-09-12 13:20:24 +0000,http://www.capitalcube.com/blog/index.php/supernus-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bearish-manner-supn-us-september-12-2016/,"Supernus Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : SUPN-US : September 12, 2016"
SUPN,SUPN:US,BBG000BP0HX7,"Commit To Buy Supernus Pharmaceuticals At $17, Earn 7.1% Annualized Using Options",2016-09-02 18:16:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VqF23zCT_5k/commit-to-buy-supernus-pharmaceuticals-at-17-earn-71-annualized-using-options-cm674237,Investors considering a purchase of Supernus Pharmaceuticals Inc Symbol SUPN stock but cautious about paying the going market price of 22 00 share might benefit from considering selling puts among the alternative strategies at their disposal One interesting put contract in particular is
SUPN,SUPN:US,BBG000BP0HX7,"This Portfolio of 5 Stocks Is Projected to Grow Its EPS by an Average of 1,028% by 2019",2016-09-01 13:22:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/w-4iAbKSGzw/this-portfolio-of-5-stocks-is-projected-to-grow-its-eps-by-an-average-of-1028-by-2019-cm673272,Image source Getty Images Do you like growth stocks Then you ve come to the right place Although the U S economy is traipsing along with GDP growth of just over 1 near record low lending rates and constant business innovation have profits at some companies soaring And when
SUPN,SUPN:US,BBG000BP0HX7,"This Portfolio of 5 Stocks Is Projected to Grow Its EPS by an Average of 1,028% by 2019",2016-09-01 11:20:07 +0000,http://www.fool.com/investing/2016/09/01/this-portfolio-of-5-stocks-is-projected-to-grow-it.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"This Portfolio of 5 Stocks Is Projected to Grow Its EPS by an Average of 1,028% by 2019"
SUPN,SUPN:US,BBG000BP0HX7,"ETF’s with exposure to Supernus Pharmaceuticals, Inc. : August 30, 2016",2016-08-30 15:34:52 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-supernus-pharmaceuticals-inc-august-30-2016/,"ETF’s with exposure to Supernus Pharmaceuticals, Inc. : August 30, 2016"
SUPN,SUPN:US,BBG000BP0HX7,"Supernus Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : SUPN-US : August 29, 2016",2016-08-29 12:04:53 +0000,http://www.capitalcube.com/blog/index.php/supernus-pharmaceuticals-inc-breached-its-50-day-moving-average-in-a-bullish-manner-supn-us-august-29-2016/,"Supernus Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : SUPN-US : August 29, 2016"
SUPN,SUPN:US,BBG000BP0HX7,"SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2016-08-24 20:38:10 +0000,http://biz.yahoo.com/e/160824/supn8-k.html,"SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
SUPN,SUPN:US,BBG000BP0HX7,Smaller Biotechs Surging to New Highs,2016-08-23 16:24:00 +0000,http://www.investopedia.com/stock-analysis/cotd/082316/smaller-biotechs-surging-new-highs-nktr-exas-nktr-exas-supn.aspx?partner=YahooSA,Smaller Biotechs Surging to New Highs
SUPN,SUPN:US,BBG000BP0HX7,Supernus' Trokendi XR Gets FDA Nod for Migraine in Adults,2016-08-22 15:48:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/OciS-AU0gVU/supernus-trokendi-xr-gets-fda-nod-for-migraine-in-adults-cm668425,"Supernus Pharmaceuticals, Inc.SUPN announced that the FDA has granted a tentative approval to the company's supplemental New Drug Application (sNDA) for a label expansion for Trokendi XR to include prophylaxis of migraine headache in adults.  We"
SUPN,SUPN:US,BBG000BP0HX7,Supernus' Trokendi XR Gets FDA Nod for Migraine in Adults,2016-08-22 13:52:01 +0000,http://finance.yahoo.com/news/supernus-trokendi-xr-gets-fda-135201529.html,Supernus' Trokendi XR Gets FDA Nod for Migraine in Adults
SUPN,SUPN:US,BBG000BP0HX7,"PFE, SUPN Get FDA Nod, SNY Will Have To Wait Till Nov., Xenetic On The Move",2016-08-22 01:34:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ySRJ_42CrKg/pfe-supn-get-fda-nod-sny-will-have-to-wait-till-nov-xenetic-on-the-move-20160822-00008,"PFE, SUPN Get FDA Nod, SNY Will Have To Wait Till Nov., Xenetic On The Move"
SUPN,SUPN:US,BBG000BP0HX7,Supernus Receives FDA Tentative Approval for Expanded Label of Trokendi XR® to Include Migraine Prophylaxis in Adults,2016-08-19 18:37:03 +0000,http://finance.yahoo.com/news/supernus-receives-fda-tentative-approval-183703180.html,"[GlobeNewswire] - ROCKVILLE, Md., Aug. 19, 2016-- Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, ..."
SUPN,SUPN:US,BBG000BP0HX7,"ETF’s with exposure to Supernus Pharmaceuticals, Inc. : August 16, 2016",2016-08-16 16:44:02 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-supernus-pharmaceuticals-inc-august-16-2016/,"ETF’s with exposure to Supernus Pharmaceuticals, Inc. : August 16, 2016"
SUPN,SUPN:US,BBG000BP0HX7,"Supernus Announces Resignation of Dr. James Barrett from Board of Directors; Charles W. Newhall, III Elected Chairman",2016-08-12 20:41:01 +0000,http://www.publicnow.com/view/55B61DF89FCB29371F81F81F465F3200EA1787FC,"[at noodls] - ROCKVILLE, Md., Aug. 12, 2016 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of ..."
SUPN,SUPN:US,BBG000BP0HX7,"SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and",2016-08-12 20:32:53 +0000,http://biz.yahoo.com/e/160812/supn8-k.html,"SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and"
SUPN,SUPN:US,BBG000BP0HX7,"Supernus Pharmaceuticals, Inc. :SUPN-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016",2016-08-09 15:47:56 +0000,http://www.capitalcube.com/blog/index.php/supernus-pharmaceuticals-inc-supn-us-earnings-analysis-q2-2016-by-the-numbers-august-9-2016/,"Supernus Pharmaceuticals, Inc. :SUPN-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016"
SUPN,SUPN:US,BBG000BP0HX7,"SUPERNUS PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report",2016-08-05 10:06:35 +0000,http://biz.yahoo.com/e/160805/supn10-q.html,"SUPERNUS PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report"
SUPN,SUPN:US,BBG000BP0HX7,Edited Transcript of SUPN earnings conference call or presentation 3-Aug-16 1:00pm GMT,2016-08-03 18:23:50 +0000,http://finance.yahoo.com/news/edited-transcript-supn-earnings-conference-182350716.html,Edited Transcript of SUPN earnings conference call or presentation 3-Aug-16 1:00pm GMT
SUPN,SUPN:US,BBG000BP0HX7,Supernus Pharmaceuticals Inc Earnings Call scheduled for 9:00 am ET today,2016-08-03 13:00:00 +0000,http://biz.yahoo.com/cc/7/153427.html,Supernus Pharmaceuticals Inc Earnings Call scheduled for 9:00 am ET today
SUPN,SUPN:US,BBG000BP0HX7,Supernus tops 2Q profit forecasts,2016-08-02 23:35:32 +0000,http://sg.finance.yahoo.com/news/supernus-tops-2q-profit-forecasts-233532237.html,Supernus tops 2Q profit forecasts
SUPN,SUPN:US,BBG000BP0HX7,Mallinckrodt (MNK) Tops Q3 Earnings on Solid Sales Growth,2016-08-02 22:56:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Y54amJmGB3k/mallinckrodt-mnk-tops-q3-earnings-on-solid-sales-growth-cm659216,"Mallinckrodt plcMNK reported adjusted earnings of $2.20 per share in the third quarter of fiscal 2016 (ended Jun 24, 2016), beating the Zacks Consensus Estimate of $2.01. Earnings were also up from the year ago figure of $2.02. Net"
SUPN,SUPN:US,BBG000BP0HX7,"AmerisourceBergen (ABC) Earnings, Revenues Beat in Q3",2016-08-02 22:56:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_VPN_svb5aE/amerisourcebergen-abc-earnings-revenues-beat-in-q3-cm659204,"AmerisourceBergen CorporationABC posted earnings (excluding one time items) of $1.37 per share in the third quarter of fiscal 2016 (ended Jun 30, 2016), beating the Zacks Consensus Estimate of $1.26 and up from $1.20 reported in the year ago"
SUPN,SUPN:US,BBG000BP0HX7,"SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements",2016-08-02 21:07:23 +0000,http://biz.yahoo.com/e/160802/supn8-k.html,"SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements"
SUPN,SUPN:US,BBG000BP0HX7,Supernus Announces Second Quarter 2016 Financial Results,2016-08-02 20:52:01 +0000,http://www.publicnow.com/view/E7901D867D014686338CDA39C3A309A091A2AA80,"[at noodls] - Second quarter 2016 product prescriptions totaled 123,758, a 38.9% increase over the second quarter of 2015. Net product sales for second quarter 2016 were $50.3 million, a 46.9% increase over the second ..."
SUPN,SUPN:US,BBG000BP0HX7,2 Biotech Funds Leading Nascent Bull Market: Which Is Right For You?,2016-08-02 20:09:55 +0000,http://www.investors.com/etfs-and-funds/etfs/2-etfs-leading-the-new-biotech-bull-market-which-is-right-for-you/,2 Biotech Funds Leading Nascent Bull Market: Which Is Right For You?
SUPN,SUPN:US,BBG000BP0HX7,Q2 2016 Supernus Pharmaceuticals Inc Earnings Release - After Market Close,2016-08-02 11:07:03 +0000,http://biz.yahoo.com/research/earncal/20160802.html?t=supn,Q2 2016 Supernus Pharmaceuticals Inc Earnings Release - After Market Close
SUPN,SUPN:US,BBG000BP0HX7,Are Biotechs Finally Making A Comeback? Here Are 5 Must-Watch Names,2016-08-01 21:02:54 +0000,http://www.investors.com/news/technology/are-biotechs-finally-making-a-comeback-here-are-5-must-watch-names/,Are Biotechs Finally Making A Comeback? Here Are 5 Must-Watch Names
SUPN,SUPN:US,BBG000BP0HX7,"ETF’s with exposure to Supernus Pharmaceuticals, Inc. : July 26, 2016",2016-07-26 17:01:11 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-supernus-pharmaceuticals-inc-july-26-2016/,"ETF’s with exposure to Supernus Pharmaceuticals, Inc. : July 26, 2016"
SUPN,SUPN:US,BBG000BP0HX7,7 Biotech Stocks to Watch for Runaway Gains,2016-07-22 12:12:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NmC661ss1Ng/7-biotech-stocks-to-watch-for-runaway-gains-cm653121,"Biotech stocks are among the riskiest places for you to invest, but it is also one of the most lucrative. Source Pixelbay (Modified)A great cure for a dreaded disease can"
SUPN,SUPN:US,BBG000BP0HX7,Supernus to Host Second Quarter 2016 Earnings Conference Call,2016-07-20 20:30:00 +0000,http://finance.yahoo.com/news/supernus-host-second-quarter-2016-203000895.html,"[GlobeNewswire] - ROCKVILLE, Md., July 20, 2016-- Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, ..."
SUPN,SUPN:US,BBG000BP0HX7,Supernus Pharma downgraded by Piper Jaffray and Northland Capital,2016-07-18 10:35:47 +0000,http://finance.yahoo.com/q/ud?s=SUPN,Supernus Pharma downgraded by Piper Jaffray and Northland Capital
SUPN,SUPN:US,BBG000BP0HX7,Supernus Pharmaceuticals Founder and CEO Jack Khattar joins scPharmaceuticals Board of Directors,2016-07-12 12:30:00 +0000,http://finance.yahoo.com/news/supernus-pharmaceuticals-founder-ceo-jack-123000938.html,"[PR Newswire] - LEXINGTON, Mass., July 12, 2016 /PRNewswire/ -- scPharmaceuticals, Inc., a privately held biopharmaceutical company developing transformative pharmaceutical products for subcutaneous delivery, announced today that Jack A. Khattar has been appointed to scPharmaceuticals' board of directors. Jack A. Khattar is the founder of Supernus Pharmaceuticals (SUPN) and has served as president and Chief Executive Officer and Director since 2005. From 1999 to 2005, Mr. Khattar served in various positions, including Board Member, president and CEO of Shire Laboratories Inc., the drug delivery subsidiary of Shire plc. Prior to that, Mr. Khattar served as an Executive Officer and the Chairman of the Management Committee at CIMA, a drug delivery company where he was also responsible for business development, corporate alliances and strategic planning."
SUPN,SUPN:US,BBG000BP0HX7,Brexit can’t stop the market from doing what it wanted to all along,2016-07-05 18:08:07 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=057B0493-039B-4FC1-9EDA-F1FAD5E0AFB3&siteid=yhoof2,Brexit can’t stop the market from doing what it wanted to all along
SUPN,SUPN:US,BBG000BP0HX7,4 health stocks to watch,2016-06-30 14:30:43 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=FC6585C7-5174-44F4-A822-728AF84E0364&siteid=yhoof2,4 health stocks to watch
SUPN,SUPN:US,BBG000BP0HX7,"SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2016-06-24 20:32:15 +0000,http://biz.yahoo.com/e/160624/supn8-k.html,"SUPERNUS PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
SUPN,SUPN:US,BBG000BP0HX7,Supernus Announces Issuance of Seventh U.S. Patent Protecting Oxtellar XR®,2016-06-22 20:30:00 +0000,http://finance.yahoo.com/news/supernus-announces-issuance-seventh-u-203000884.html,"[GlobeNewswire] - ROCKVILLE, Md., June 22, 2016-- Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, ..."
SUPN,SUPN:US,BBG000BP0HX7,"CAPR Vaults On Study, CRBP Awaits Data In Q4, OASIS A Shot In The Arm For PRTK",2016-06-17 02:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gCwTkWbGmbQ/capr-vaults-on-study-crbp-awaits-data-in-q4-oasis-a-shot-in-the-arm-for-prtk-20160617-00021,"CAPR Vaults On Study, CRBP Awaits Data In Q4, OASIS A Shot In The Arm For PRTK"
SUPN,SUPN:US,BBG000BP0HX7,Supernus Announces Issuance of Sixth U.S. Patent Protecting Oxtellar XR®,2016-06-02 12:15:04 +0000,http://www.publicnow.com/view/FD0A74B09E2A41D0CE3C5BDDE05932AEF9A51F3B,"[at noodls] - June 2, 2016 ROCKVILLE, Md., June 02, 2016 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the ..."
SUPN,SUPN:US,BBG000BP0HX7,Supernus to Present at June Jefferies Healthcare Conference,2016-05-24 21:36:07 +0000,http://www.publicnow.com/view/F8EFF2C838718683AA6C88BE305A0650C5055620,"[at noodls] - May 24, 2016 ROCKVILLE, Md., May 24, 2016 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the ..."
SUPN,SUPN:US,BBG000BP0HX7,4 Momentum Stocks to Watch,2016-05-24 15:26:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-Na6eJFR90w/4-momentum-stocks-to-watch-cm625531,"By Harry Boxer   Here are four momentum stocks to watch in technology, energy, pharma and biotech.   Universal Display Corp.  ( OLED ), in an up-channel off its February low, recently traversed from the top of the channel to the bottom.  But the lower trendline held, as the stock popped the last two sessions,"
SUPN,SUPN:US,BBG000BP0HX7,Supernus Enters Into Partial Settlement Agreement with Actavis on Oxtellar XR®,2016-05-10 12:38:07 +0000,http://www.publicnow.com/view/B8A2718D3125278D9DFB24E4C5A0F120D169953D,"[at noodls] - May 10, 2016 ROCKVILLE, Md., May 10, 2016 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the ..."
SUPN,SUPN:US,BBG000BP0HX7,Supernus Announces First Quarter 2016 Financial Results,2016-05-03 21:20:11 +0000,http://www.publicnow.com/view/EFF62B0A9286BC10B2E3E63CCD191F8F433010F9,"[at noodls] - May 3, 2016 First quarter 2016 product prescriptions totaled 114,773, representing a 49.7% increase over the first quarter of 2015. Net product sales for first quarter 2016 were $43.0 million, a 53.1% ..."
SUPN,SUPN:US,BBG000BP0HX7,Supernus to Host First Quarter 2016 Earnings Conference Call,2016-04-19 16:30:11 +0000,http://www.publicnow.com/view/1ADC55085EDC356077D3D7A0FB16103087C0A5DB,"[at noodls] - April 19, 2016 ROCKVILLE, Md., April 19, 2016 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a specialty pharmaceutical company focused on developing and commercializing products for ..."
SUPN,SUPN:US,BBG000BP0HX7,Supernus tops 4Q profit forecasts,2016-03-02 23:09:37 +0000,http://sg.finance.yahoo.com/news/supernus-tops-4q-profit-forecasts-230937428.html,Supernus tops 4Q profit forecasts
SUPN,SUPN:US,BBG000BP0HX7,"After-Hours Earnings Report for March 2, 2016 :  COST, AEO, SINA, TSE, SMTC, ALOG, JOBS, LHCG, SUPN, HRTG, CPE, RVNC",2016-03-02 20:10:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Jqdz0qpa8VM/after-hours-earnings-report-for-march-2-2016-cost-aeo-sina-tse-smtc-alog-jobs-lhcg-supn-hrtg-cpe-rvnc-cm587455,The following companies are expected to report earnings after hours on 03 02 2016. Visit our Earnings Calendar for a full list of expected earnings releases.  Costco Wholesale Corporation ( COST ) is reporting for the
SUPN,SUPN:US,BBG000BP0HX7,Supernus Announces Distribution of Common Stock by NEA,2015-12-04 14:40:18 +0000,http://www.noodls.com/view/C8C45651A021D48EE84B66616C6780D1563C7D77,"[at noodls] - December 4, 2015 ROCKVILLE, Md., Dec. 4, 2015 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a specialty pharmaceutical company focused on developing and commercializing products for ..."
SUPN,SUPN:US,BBG000BP0HX7,Supernus to Attend Guggenheim Securities Boston Healthcare Conference,2015-12-02 22:00:28 +0000,http://www.noodls.com/view/64BEFD0EB19AE1D0A220A2C60571AB50282E9808,"[at noodls] - December 2, 2015 ROCKVILLE, Md., Dec. 2, 2015 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a specialty pharmaceutical company focused on developing and commercializing products for ..."
SUPN,SUPN:US,BBG000BP0HX7,Supernus Pharmaceuticals Is Dropping -- Is It a Buy?,2015-11-12 19:53:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TRy8hjwnfWE/supernus-pharmaceuticals-is-dropping-is-it-a-buy-cm542478,"What  A bit more than a week after reporting earnings and ahead of an investor conference next week, shares in Supernus Pharmaceuticals fell by 13% earlier today.  Let's take a closer"
SUPN,SUPN:US,BBG000BP0HX7,Supernus beats Street 3Q forecasts,2015-11-04 00:07:52 +0000,http://sg.finance.yahoo.com/news/supernus-beats-street-3q-forecasts-000752372.html,Supernus beats Street 3Q forecasts
SUPN,SUPN:US,BBG000BP0HX7,Supernus Announces Third Quarter 2015 Financial Results and Raises 2015 Guidance,2015-11-03 22:57:06 +0000,http://www.noodls.com/view/78210CC32ABCB4875AEBCEF586DCDAE834A4CC26,"[at noodls] - November 3, 2015 Third quarter product prescriptions totaled 102,831, representing a 78.0% increase over the same quarter last year and a 12.6% increase over the second quarter of 2015. Net product sales ..."
SUPN,SUPN:US,BBG000BP0HX7,Should You Buy Supernus Pharmaceuticals (SUPN) Ahead of Earnings?,2015-11-02 16:27:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jfPqqIIwjNQ/should-you-buy-supernus-pharmaceuticals-supn-ahead-of-earnings-cm537529,"Investors are always looking for stocks that are poised to beat at earnings season and Supernus Pharmaceuticals, Inc.SUPN may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for"
SUPN,SUPN:US,BBG000BP0HX7,7 Small-Cap Stocks to Buy for Gigantic Growth,2015-11-02 16:08:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BhRwObH9MN8/7-small-cap-stocks-to-buy-for-gigantic-growth-cm537569,"By Alyssa Oursler, InvestorPlace Contributor   Despite recent momentum, the S&P 500 is barely spilling black ink in 2015. And while small-cap stocks are typically a go-to source for outsized gains, “risk-on” hasn’t exactly been the order of the day, with the Russell 2000 faring worse than the broader market at"
SUPN,SUPN:US,BBG000BP0HX7,"Health Care Sector Update for 10/28/2015: SUPN, BSX, GNMK",2015-10-28 14:00:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VHYLMxsOXBI/health-care-sector-update-for-10282015-supn-bsx-gnmk-cm535613,"Top Health care stocks JNJ flat PFE 0.1% ABT flat MRK flat AMGN flat Health care shares were mainly unchanged in pre market trade Wednesday. In health care stocks news, Supernus Pharmaceuticals ( SUPN ) shares were initiated by"
SUPN,SUPN:US,BBG000BP0HX7,Supernus Inks Trokendi XR Settlement Agreement with Endo,2015-10-20 22:44:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/P0qvJWXoUd8/supernus-inks-trokendi-xr-settlement-agreement-with-endo-cm532665,"Supernus Pharmaceuticals, Inc.SUPN has entered into a settlement agreement with Par Pharmaceutical Companies, a wholly owned subsidiary of Endo International plc ENDP for an ongoing patent litigation regarding Trokendi XR (extended release topiramate). We remind investors that on Dec"
SUPN,SUPN:US,BBG000BP0HX7,Supernus to Host Third Quarter 2015 Earnings Conference Call,2015-10-20 20:23:13 +0000,http://www.noodls.com/view/CED260D4686916EB8915A3DF2EA5C8FD7958896D,[at noodls] - Supernus to Host Third Quarter 2015 Earnings Conference Call
SUPN,SUPN:US,BBG000BP0HX7,Supernus Announces Settlement With Par on Trokendi XR(R) Patent Litigation,2015-10-15 13:02:04 +0000,http://www.noodls.com/view/A4EB4BFFCE0BF4DE7F337A296F93E7A2CD1F51F4,[at noodls] - Supernus Announces Settlement With Par on Trokendi XR(R) Patent Litigation
SUPN,SUPN:US,BBG000BP0HX7,3 Stocks with Jaw-Dropping Growth Potential,2015-10-11 14:58:56 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ho9M1bNGZNY/3-stocks-with-jaw-dropping-growth-potential-cm529172,"Source  Pixabay  The market hasn't been particularly kind to healthcare stocks in general, of late, and biotech stocks in particular are being shunned. But that doesn't mean investors should necessarily follow"
SUPN,SUPN:US,BBG000BP0HX7,The Fastest-Growing Biotech Stocks,2015-09-21 23:35:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9wKHLm6uVdE/the-fastest-growing-biotech-stocks-cm522202,"Source  Flickr user Maryland GovPics.  Even after the first correction in four years, biotech stocks are absolutely crushing the S&P 500 over the trailing five year period. In fact, the SPDR"
SUPN,SUPN:US,BBG000BP0HX7,Catalyst (CPRX) to Develop Generic Version of Sanofi's Sabril,2015-09-10 20:18:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JP53Z0Mmmjc/catalyst-cprx-to-develop-generic-version-of-sanofis-sabril-cm518856,"Catalyst Pharmaceuticals, Inc.CPRX announced that it has launched a complex, high barrier program to develop its generic version of Sabril (vigabatrin), which is marketed in the U.S. by Lundbeck Inc. and in the EU by Sanofi SNY . Sabril"
SUPN,SUPN:US,BBG000BP0HX7,Supernus Announces Issuance of Fifth U.S. Patent Protecting Oxtellar XR(R),2015-09-02 21:24:06 +0000,http://www.noodls.com/view/4C2A53C7DE57E4BB6F64900807E231A86AB9F6F3,"[at noodls] - ROCKVILLE, Md., Sept. 2, 2015 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of ..."
SUPN,SUPN:US,BBG000BP0HX7,Supernus to Attend FBR Healthcare Conference on September 9th,2015-08-27 20:44:18 +0000,http://www.noodls.com/view/C7DBBC34B525142F14EAE4E49F979929AA833DC5,"[at noodls] - ROCKVILLE, Md., Aug. 27, 2015 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN), a specialty pharmaceutical company focused on developing and commercializing products for the treatment of ..."
SUPN,SUPN:US,BBG000BP0HX7,Why Supernus Pharmaceuticals Inc. Shares Are Soaring,2015-06-12 20:23:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7EMk3TbaRxc/why-supernus-pharmaceuticals-inc-shares-are-soaring-cm486636,"Although we don't believe intiming the market or panicking over market movements, we do like to keep an eye on big changes    just in case they're material to our investing thesis."
SUPN,SUPN:US,BBG000BP0HX7,Can the Rally in Supernus Pharmaceuticals (SUPN) Shares Continue? - Tale of the Tape,2015-06-08 14:25:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_gnAOQt_QvQ/can-the-rally-in-supernus-pharmaceuticals-supn-shares-continue-tale-of-the-tape-cm484453,"Supernus Pharmaceuticals Inc ( SUPN ) has been on the move lately as the stock has risen by 18.7% in the past four weeks, and it is currently trading well above its 20 Day SMA. This is a pretty"
SUPN,SUPN:US,BBG000BP0HX7,Supernus posts 1Q profit,2015-05-05 21:03:33 +0000,http://sg.finance.yahoo.com/news/supernus-posts-1q-profit-210333467.html,Supernus posts 1Q profit
SUPN,SUPN:US,BBG000BP0HX7,Supernus beats Street 4Q forecasts,2015-03-10 22:02:11 +0000,http://sg.finance.yahoo.com/news/supernus-beats-street-4q-forecasts-220211955.html,Supernus beats Street 4Q forecasts
SUPN,SUPN:US,BBG000BP0HX7,Supernus misses 3Q profit forecasts,2014-11-11 21:57:58 +0000,http://sg.finance.yahoo.com/news/supernus-misses-3q-profit-forecasts-215758700--finance.html,Supernus misses 3Q profit forecasts
